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ABSTRACT 
Developmental protein restriction is associated with numerous diseases including obesity, 
diabetes and cardiovascular disease, both in the mother and offspring. Recent intensive 
research efforts have focused on the mechanisms behind the effects of a maternal low protein 
diet on diseases in offspring. However, thus far, the mechanisms behind the physiological and 
molecular adaptations in the mother in response to protein restriction during pregnancy and 
lactation are not well understood. Because skeletal muscle and liver have a critical role in 
energy metabolism, including pregnancy and lactation-associated metabolic adaptations, the 
present study will investigate the genetic and epigenetic mechanisms behind the physiological 
changes that occur in response to a protein restricted diet during pregnancy and lactation in the 
skeletal muscle and liver of rat dams. The amino acid response (AAR) pathway is important in 
responding to stress, such as amino acid limitation, and our previous data show that a protein 
restriction diet during pregnancy induces the AAR pathway in placenta and causes stunted 
growth in the offspring. The central regulator of the AAR pathway is the activating transcription 
factor 4, ATF4. It has been shown that ATF4 can regulate macroautophagy in response to 
amino acid limitation. The process of autophagy is essential for the maintenance of cellular 
homeostasis, and our results show that a gestational low protein (LP) diet induces the mRNA 
expression of autophagy-related genes in the skeletal muscle of rat dams and male offspring, 
providing strong evidence of maternal programming. Additionally, our study shows that a 
gestational and lactational LP diet stimulates autophagy and hepatic lipid accumulation, and 
decreases expression of histone deacetylase-3 (Hdac3) in the liver of rat dams. Histone 
acetylation is associated with increased gene transcription. Specifically, it has been reported 
that HDAC3 inhibition induces LC3B expression, a primary autophagy marker and lipid 
accumulation. More importantly, we show that amino acid limitation induces autophagy through 
HDAC3-dependent expression of LC3B and its increased association with lipid droplets in a 
hepatic cell line, HepG2. Investigating the role that HDAC3 may play in the activation of LC3B 
and lipid accumulation will bring valuable insight into the epigenetic control of hepatic lipid 
accumulation by a LP diet during pregnancy and lactation in rat dams. In summary, our results 
demonstrate that protein restriction during gestation and lactation induces autophagy in skeletal 
muscle and liver, respectively; investigating the epigenetic regulation of autophagy will shed 
light on potential therapies that could diagnose and treat imbalanced maternal nutrition-related 
metabolic disorders in mother and offspring. 
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CHAPTER 1  
INTRODUCTION 
1.1 Significance 
The present study will bridge the knowledge gap between maternal protein restriction-induced 
physiological disorders and autophagy-related molecular pathways, and further shed light on the 
prevention of and intervention for post-pregnancy diseases in the mother. To our knowledge, 
this study is among the first to focus on maternal programming, autophagy and epigenetics in 
response to gestational and lactational protein restriction both in in vivo and in vitro models. 
Most importantly, our study is among the first to integrate the study of epigenetics, especially 
HDAC3-regulated histone acetylation of the LC3b gene (the marker of autophagy activation) 
with lipid accumulation in liver. The purpose of the present study was to characterize the 
epigenetic regulation of autophagy in response to protein restriction during pregnancy and 
lactation in rat dams, which provides valuable insight into understanding the role that autophagy 
plays in maternal programming, potentially through epigenetic regulation in metabolic tissues 
including skeletal muscle and liver. 
 
1.2 Objective 
The objective of this study was to determine whether autophagy is induced and regulated by, 
and the potential consequences of protein restriction during pregnancy and lactation in skeletal 
muscle and liver of rat dams. 
 
1.3 Central Hypothesis  
Protein restriction during pregnancy and lactation induces autophagy in a time- and tissue-
dependent manner, and causes skeletal muscle atrophy after gestation and hepatic lipid 
accumulation after lactation in rat dams. 
 
1.4 Specific Aims 
A LP diet during pregnancy and lactation in rat dams causes adverse consequences in the 
mother including gestational diabetes, obesity and fatty liver diseases. However, in comparison 
to the intensive studies in offspring, the genetic and epigenetic mechanisms behind the 
physiological consequences of a protein deficient diet in the mother during pregnancy and 
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lactation are not well understood. It has been shown that during pregnancy, lean tissue including 
skeletal muscle has the most substantial role in the maintenance of active protein metabolism in 
rat dam (1-3), making it the most vulnerable organ in response to protein restriction during 
pregnancy.  Additionally, it has been shown that a protein restricted diet during pregnancy and 
lactation increases lipid accumulation in rats’ liver which is associated with dysregulation of lipid 
metabolism (4). Furthermore, amino acid starvation induces autophagy in myocytes (5) and 
hepatocytes (6). Autophagy is associated with the degradation of cellular components, including 
protein and free fatty acid mobilization through the regulation of LC3 machinery. It has also been 
shown that lipid-containing autophagic vacuoles are increased in the liver of fasted mice 
compared to fed mice (7). Regulation of LC3 relies on transcriptional control. Histone 
acetylation, one of the epigenetic modifications of histones, serves as a key modulator of 
chromatin structure and transcription (8). Histone acetylation can be induced by inhibition of a 
family of key enzymes, histone deacetylases (HDACs) (9). It has been shown that inhibitions of 
HDACs is associated with induced autophagy and increased expression of LC3-II (LC3B) in in 
vitro cell models (10-12). Furthermore, deletion of HDAC3 in the liver disrupts lipid and 
cholesterol homeostasis, leading to an accumulation of lipids and a decrease in glycogen 
storage (13). 
 
The proposed hypotheses were tested by pursuing the following specific aims: 
Specific Aim 1:  
Characterize the physiological and molecular outcomes of a protein-restricted diet during 
pregnancy in rat dams. 
 
 I hypothesized that a gestational LP diet would cause decreased pregnancy body weight 
and skeletal muscle atrophy in rat dam, and these changes would be associated with induced 
autophagy-related genes in the skeletal muscle. Additionally, I proposed that autophagy-related 
genes will be increased in the skeletal muscle of offspring, in a sex-dependent manner. 
 
Specific Aim 2: 
Characterize the physiological and molecular outcomes of a protein restricted diet during 
pregnancy and lactation in rat dams, and determine the molecular mechanism behind this 
phenomenon.  
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Aim 2A: 
Characterize the physiological and molecular outcomes of a protein-restricted diet during 
pregnancy and lactation in the liver of rat dams. 
 
I hypothesized that a gestational and lactational LP diet would cause increased 
hepatic lipid accumulation and damage liver function in rat dam, and these changes 
would be associated with induced LC3B, a primary autophagy marker and decreased 
mRNA expression of Hdac3 in rat liver.  
 
Aim 2B: 
Establish an in vitro model to assess whether amino acid limitation induces autophagy 
and lipid droplets formation in hepatic cells (referred to as lipophagy).  
 
I first hypothesized that amino acid limitation in vitro will induce LC3B expression, 
associated with increased lipid droplet formation in hepatic cells. Therefore, my goal was 
to then determine whether amino acid limitation-induced LC3B expression was 
associated with increased lipid droplet formation in HepG2 cells.  
 
Aim 2C: 
Determine whether HDAC3 regulates amino acid limitation-induced lipophagy in hepatic 
HepG2 cells.  
 
I first hypothesized that decreased HDAC3 would contribute to amino acid 
limitation-induced lipophagy in hepatic cells. Therefore, my goal was then to utilize an 
established cell model to investigate the role of HDAC3 in regulating amino acid 
limitation-induced lipophagy in HepG2 cells. 
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CHAPTER 2  
LITERATURE REVIEW 
2.1 Maternal Adaptation During Pregnancy and Lactation 
Macronutrient requirements and maternal adaptation  
Maternal metabolism is altered drastically during pregnancy and lactation, and maternal nutrition 
is essential to support these changes (14, 15). Dietary macronutrients (protein, carbohydrates 
and fat) play a critical role in regulating metabolism both in mother and fetus. Table 2.1 presents 
an overview of outcomes from studies discussed next as well as from several others.  
Pregnant women require 25 g/d of additional protein to support fetal development (16). 
Also, pregnancy causes increased whole body protein turnover and decreased urea synthesis in 
women (17-19). The adaptation of protein metabolism through the accumulation and breakdown 
of protein stores is an essential component of the maternal adaptation to pregnancy (20). 
Pregnancy is often associated with hypoaminoacidemia and urinary nitrogen losses during 
fasting, which is evident early in gestation and persists throughout pregnancy (21, 22). The 
major source of urea nitrogen during pregnancy is peripheral (muscle) release of amino acids 
(20), and Kalkhoff, et al. showed a positive correlation between total circulating amino acid 
concentrations and neonatal birth weight (23). During pregnancy, maternal carbohydrate 
metabolism adapts to the needs of the developing embryo and in preparation for milk production 
by increasing glucose uptake and metabolism (24). The recommended RDA for carbohydrate 
consumption during pregnancy is 175 g/d. Basal hepatic glucose production is increased by 
16%-17% and gluconeogenesis is increased during pregnancy, however, maternal blood 
glucose is decreased (25-27). The increased glucose production in mother provides fuel for 
embryo and fetal development during pregnancy. Fat is another important macronutrient that 
prepares the mother for milk production after delivery. Placental lactogen alters maternal lipid 
metabolism (28), so that maternal fat storage is increased early in pregnancy, while circulating 
triacylglycerol, VLDL, LDL and HDL are increased in late pregnancy (28, 29). 
After delivery, maternal metabolism adapts for the maintenance of optimal nutritional 
status and adequate milk production. The RDA of protein consumption in lactating women is the 
same as pregnant women: 25 g/d of additional protein (16). During lactation, mother has 
increased nitrogen flux, decreased rates of protein synthesis and degradation and the net 
protein retention is increased (30, 31). Lactating women require more energy for milk production 
and the RDA for carbohydrate consumption is 210 g/d (16). During lactation, carbohydrate 
	  	   5	  
utilization and total energy expenditure are increased to meet the increasing energy demand 
(32, 33). Moreover, lactating women show increased fat mobilization and HDL constituents 
indicating lipid metabolism is activated to support the process of lactation (34-37). 
 
Protein restriction and maternal programming 
Compromised nutritional environment during early development could cause immediate health 
problems in newborns, as well as growth retardation, obesity and type II diabetes during 
adulthood. A mounting body of evidence has demonstrated that perinatal undernutrition 
profoundly alters the intrauterine environment, leading to permanent phenotypic alterations with 
adverse physiological outcomes that persist throughout adulthood in the offspring. The role of 
maternal protein balance in both maternal health and gestational outcomes highlights the 
importance of the maternal diet. Maternal programming by in utero nutrition sheds light on the 
underlying mechanism between maternal protein restriction and offspring metabolic syndrome 
(Figure 2.1).  
The concept of maternal programming originates from David J. Barker’s “fetal origins” 
hypothesis, who proposed that inadequate in utero nutrition “programs” early and chronic 
diseases in offspring (40). Over the last several decades, the Barker hypothesis has produced a 
new branch of scientific study known as the developmental origins of health and disease 
(DOHaD). DOHaD combines two key ideas. First, the effects of fetal conditions are persistent 
from early age to adulthood. Second, the hypothesized effects reflect a specific biological 
mechanism, which is known as fetal “programming,” possibly through the effects of environment 
on the epigenome. The epigenome can be considered as a series of modifiable switches that 
cause various parts of the genome to be expressed – or not expressed, without changing the 
original genetic code. The perinatal period may be particularly critical for establishing these 
switches (41).  
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Table 2.1: Macronutrient requirements during gestation and lactation in humans 
Maternal stage Macronutrients Daily requirement (RDA) Metabolism References 
Gestation 
Protein 
1.1 g/kg/d of protein or 
+25 g/d of additional 
protein 
↑whole body protein turnover, ↓urea synthesis 
Kalhan and Devapatla (18); Kalhan, 
et al.(19); Book chapter (16); Alaimo, 
et al. (17) 
Carbohydrate 175 g/d 
↓maternal blood glucose, ↑basal hepatic glucose 
production increased by 16%-30%; ↑ 
gluconeogenesis 
Catalano, et al. (25); Assel, et al. 
(26); Kalhan, et al. (27) 
Lipid ND 
↑lipolysis by placental lactogen, ↑maternal storage of 
fat; ↑plasma levels of most lipid fractions, including 
triacylglycerol, VLDL, LDL and HDL 
Knopp, et al. (28); Burt and Davidson 
(29) 
Lactation 
Protein 
1.3 g/kg/d of protein or 
+25 g/d of additional 
protein 
↑nitrogen flux, ↓rates of protein degradation and 
synthesis, ↑net protein retention 
Motil, et al. (30); Motil, et al. (31) 
Carbohydrate 210 g/d 
↑carbohydrate utilization and ↑total energy 
expenditure 
Buttle, et al. (32); Stuebe and Rich-
Edwards (33) 
Lipid ND ↑fat mobilization, ↑HDL constituents 
Vanraaij, et al. (34) Brewer, et al. 
(35); Sadurskis, et al. (38); Knopp, et 
al. (39)); Gunderson, et al. (36) 
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Figure 2.1: A schematic model of maternal programming by protein restriction. Perinatal 
exposure to protein restriction during gestation and lactation stimulates the “protein restriction 
signal” in placenta, which supports fetal development in utero. Consequently, the “protein 
restriction signal” programs metabolic syndrome in the offspring. Adapted from de Gusmao 
Correia, et al (42).  
      
 
Common animal models for studying maternal programming via protein restriction 
Because of the shorter life span of animals and because genetic and environmental influences 
can be carefully monitored in animals, a substantial effort in recent years has focused on the 
establishment of animal models of maternal programming that closely model the human 
condition. Not surprisingly, results from these studies in animals have many shared metabolic 
phenotypic outcomes in the offspring with what has been observed in humans.  
The rodent is the most commonly used model species for investigating maternal 
programming via a perinatal and nutritional environment, even when compared to other 
common models including sheep, cow, and nonhuman primates (43). Because of this, the low-
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protein (LP) rodent model is one of the best-characterized developmental programming models, 
demonstrating that even a marginal protein restriction (8% protein) during pregnancy has 
physiological impacts both for the mother and offspring (44). A gestational LP diet is associated 
with reduced body weight gain in pregnant rats (45) and a gestational and lactational LP diet is 
shown to impair differentiation of mammary gland cells and favor lipid accumulation through 
alteration of lipid metabolism including increased lipogenesis in the liver and adipose tissue in 
rat dams (4, 46). Armitage, et al. (47) reviewed numerous studies with varying levels of protein 
restricted diets used in studies of maternal programming in offspring. And the majority of the 
studies from the review focus on the Wistar rats, with 6, 8, or 9% protein composition when 
compared to 18-20% protein in the average control diet. An 8% protein-restricted diet during 
pregnancy and lactation programmed an increase in hepatic glycogen content in male offspring 
(48), and male offspring of dams fed an 8% protein-restricted diet during pregnancy and 
lactation has increased risks of arterial hypertension (49). Our group reported that a 9% protein-
restricted diet during pregnancy resulted in stunted growth in male offspring of rats (50). 
Furthermore, a 9% protein-restricted diet during pregnancy resulted in vascular dysfunction 
(51), increased susceptibility of oxidative stress (52), increased fat deposition, and altered 
feeding behavior (53, 54) in male offspring of rats. 
Maternal protein-restricted diet during pregnancy and lactation also programs improved 
adaptation of carbohydrate metabolism in female offspring. A 6% protein restricted diet during 
pregnancy programs an increase in glycogen content, a decrease in mitochondria swelling and 
O2 uptake in both liver and muscle in female offspring indicating inhibition of lipid peroxidation 
(55). Additionally, increased fasting plasma glucose, coincided with increased insulin level has 
been shown in female offspring of rat dam fed an 8% protein restricted diet during pregnancy 
and lactation (56). Moreover, a 10% protein restricted during pregnancy and lactation impairs 
reproductive capacity in female offspring through decreasing LH level and increasing FSH level, 
and consequently results in reduction of numbers of prenatal and atrial follicles (57). A 10% 
protein restricted diet during pregnancy and lactation also programs brain function in female 
offspring, which associated with increased anxiety and impaired learning and memory (58). 
Mice show similar features of maternal programming by 5-8% protein-restricted diet during 
pregnancy and lactation. The various models are summarized (Table 2.2). Numerous reports 
have shown that maternal dietary deficiencies of other macro- and micronutrients can result in 
chronic diseases in offspring, including coronary heart disease, hypertension, and type II 
diabetes (59-63). 
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Table 2.2: Common rodent models to study maternal programming via protein restriction 
Experimental rodent models Observations in offspring 
Metabolism-related 
observations in offspring 
References 
Rats exposed to 9% protein restriction during 
pregnancy and lactation 
↓growth development in male offspring 
 
Strakovsky, et al 
(50) 
Rats exposed to 8% protein restriction during 
pregnancy and lactation 
↑hepatic glycogen content in male offspring ↓glycogen degradation Gosby, et al. (48) 
Rats exposed to 8% protein restriction during 
pregnancy and lactation 
↑risks of arterial hypertension in male offspring 
 
de Brito Alves, et al. 
(49) 
Rats exposed to 9% protein restriction during 
pregnancy 
↑systolic blood pressure, impaired acetylcholine-
induced vasodilatation in male offspring  
Torrens, et al. (51) 
Rats exposed to 9% protein restriction during 
pregnancy 
↑protein carbonyl concentrations in the liver, 
↑glutathione peroxidase activity in male offspring 
↑susceptibility of oxidative stress 
in male offspring 
Langley-Evans and 
Sculley (52) 
Rats exposed to 9% protein restriction during 
pregnancy 
↑fat deposition, and altered locomoter activity in male 
offspring  
Bellinger, et al. (53, 
54) 
Rats exposed to 8% protein restriction during 
pregnancy and lactation 
Transient altered circulating amino acid concentration 
in male offspring 
Altered protein metabolism 
Alexandre-
Gouabau, et al. (64) 
Rats exposed to 10% protein restriction during 
pregnancy 
↓the germinal epithelium development 
 
Rodriguez-
Gonzalez, et al. 
(65) 
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Table 2.2: Common rodent models to study maternal programming via protein restriction (Continued)  
Rats exposed to 8% protein restriction during 
pregnancy and lactation 
↑fasting glucose and plasma insulin in female 
offspring 
Impaired glucose homeostasis 
Fernandez-Twinn, 
et al. (56) 
Rats exposed to 6% protein restriction during 
pregnancy 
↑hepatic and muscle glycogen, ↓mitochondria swelling 
and O2 uptake in female offspring 
↓lipid peroxidation Moraes, et al. (55) 
Rats exposed to10% protein restriction during 
pregnancy and lactation 
↓numbers of prenatal and atrial follicles, ↓LH levels 
and ↑FSH in female offspring 
↓onset of puberty, decreased 
fertility 
Guzman, et al. (57) 
Rats exposed to10% protein restriction during 
pregnancy and lactation 
↑anxiety behavior, learning impairment in female 
offspring  
Reyes-Castro, et al. 
(58) 
Mice exposed to 8% protein restriction during 
pregnancy 
Catch-up growth, ↓longevity in male offspring 
 
Chen, et al. (66) 
Mice exposed to 5% protein restriction during 
pregnancy 
↓development of coronary arteries in embryos 
 
Silva-Junior, et al. 
(67) 
Mice exposed to 5% protein restriction during 
pregnancy 
Hypercholesterolemia, hypertriacylglycerolaemia, 
hyperglycemia, ↑adiposity in male offspring  
Peixoto-Silva, et al. 
(68) 
Mice exposed to 5% protein restriction during 
pregnancy 
↓beta cell mass and causes hypoinsulinemia in male 
offspring 
↓pancreatic islets and altered 
distribution of alpha/beta cells 
Frantz, et al. (69) 
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2.2 Molecular Pathways Impacted by Maternal Protein Restriction During Pregnancy and 
Lactation  
Protein restriction during pregnancy and lactation influences numerous molecular events in both 
mother and offspring, including the well-studied Amino Acid Response (AAR) pathway (70). 
AAR pathway activation in response to amino acid limitation occurs largely through signal 
transduction mediated altered transcriptional activity of specific genes, including Asns (71), Atf3 
(72) and Chop (73, 74). Activation of the AAR pathway requires phosphorylation of the 
eukaryotic translation initiation factor 2α (eIF2α) by GCN2 kinase leading to the decrease of 
global protein synthesis (75) but an increase in the synthesis of ATF4 protein (75-77), which 
activates multiple stress-induced genes, including genes containing an amino acid response 
element (AARE) (78). Therefore, ATF4 appears to serve as a master regulator of the AAR 
pathway, further supported by observations that ATF4 binds at the Asns (79) and Atf3 (80) 
promoter regions. Our group has shown that a protein-restricted diet during pregnancy and 
lactation activates the AAR pathway in placenta (50). Also, the AAR pathway is activated in 
skeletal muscle of both rat dams fed a gestational protein-restricted diet and their female 
offspring (81).  
Protein restriction during pregnancy and lactation alters molecular events in numerous 
organs in offspring. In skeletal muscle, protein restriction during pregnancy decreased insulin 
signaling pathway-related protein and gene expression, including IRS1 and PKCθ in mice (66). 
Furthermore, C/EBPβ and Pepck mRNA expression are downregulated by protein restriction 
during pregnancy in skeletal muscle of female offspring rats (82). In rat liver, protein restriction 
during pregnancy decreases LXRα expression and increases mRNA expression of 11β-HSD1 
and G6Pase, suggesting impaired gluconeogenic pathways and increased risks of glucose 
intolerance (83). Protein restriction during pregnancy and lactation also increases adipogenesis 
through increased mRNA expression of C/EBPα and PPARɣ in white adipose tissue in rats (84). 
Moreover, maternal protein restriction alters angiotensinogen/renin system in the pancreas 
through increased protein expression of angiotensin, ACE-1 and renin (85). Numerous other 
tissues and molecular pathways have been shown to be altered by maternal protein restriction 
in rat offspring, including increased fatty acid oxidation-related gene, Cpt1 in heart (86), and 
decreased cell cycle-related gene mRNA and protein expression of P21 in mammary gland (87). 
The various molecular evens are summarized (Table 2.3). 
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Table 2.3: Molecular events underlying the programming of diseases in rodent offspring by maternal protein restriction during 
pregnancy and lactation in rodents 
Experimental models Tissues Molecular evidence Reference 
Mice exposed to 8% protein restriction during 
pregnancy 
Muscle 
↑mRNA expression of IRS1 and PKCθ; ↓protein levels of insulin signaling 
pathway including PI3 kinase subunits p85α, p110β 
Chen, et al. (66) 
Rats exposed to 9% protein restriction during 
pregnancy 
Muscle ↑mRNA and protein expression of C/EBPβ, ↑mRNA expression of Pepck Zheng, et al. (82) 
Mice exposed to 8% protein restriction during 
pregnancy 
Liver 
↑mRNA expression of PPAR signaling pathways genes including Aqp7, 
Cpt1b, Lpl and PPARɣ 
Zheng, et al. 
(9737) 
Rats exposed to 8% protein restriction during 
pregnancy 
Liver 
↓LXRα expression, ↑hepatic expression of 11β-HSD1 and G6Pase and 
↓binding of LXRα on those two genes 
Vo, et al. (83) 
Rats exposed to 8% protein restriction during 
pregnancy and lactation 
Liver ↓cholesterol 7α-hydroxylase (Cyp7a1) Sohi, et al. (88) 
Rats exposed to 9% protein restriction during 
pregnancy 
Liver 
↓mRNA expression of Dnmt1, Mcm6, AurKB, Hat1 and Gmnn; ↑mRNA 
expression of Dnm3a, Dmt3b and Gnmt 
Altobell, et al. (89) 
Rats exposed to 8% protein restriction during 
pregnancy and lactation 
White adipose 
tissue 
↑C/EBPα and PPARɣ mRNA expression Guan, et al. (84) 
Rats exposed to 6% protein restriction during 
pregnancy 
Intestine ↑mRNA expression lactase of sucrase in duodenum 
Pinheiro, et al. 
(90) 
Rats exposed to 6% and 9% protein 
restriction during pregnancy 
Kidney ↑apoptosis-related pathway gene expression, Bcl2 and Bax 
Welham, et al. 
(91) 
Rats exposed to 8% protein restriction during 
pregnancy and lactation 
Pancreas 
↑miRNA-375 expression, ↓PDK1 protein expression, ↑mRNA expression 
CCND2 and p57, ↓mRNA expression of CCNA2 and CDK4 
Dumortier, et al. 
(92) 
Mice exposed to 5% protein restriction during 
pregnancy 
Pancreas 
↑angiotensinogen and ACE-1 mRNA and protein expression, ↑renin protein 
expression 
Goyal, et al. (85) 
Rats exposed to 9% protein restriction during 
pregnancy 
Heart ↑mRNA expression of PPARα and Cpt1 
Slater-Jefferies, 
et al. (86) 
Rats exposed to 9% protein restriction during 
pregnancy 
Mammary 
gland 
↓mRNA and protein expression of P21 Zheng, et al. (87) 
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2.3 Autophagy in Mammalian Cells 
Overview of autophagy  
Autophagy is a cellular degradation and survival process that is highly conserved in most 
eukaryotes. In mammalian cells, there are three major types of autophagy including 
microautophagy, macroautophagy, and chaperone-mediated autophagy (CMA). Although each 
of them is morphologically different, all three culminate in the delivery of cargo to the lysosome 
for degradation and recycling (93). Microautophagy is a process where cytoplasmic contents 
enter into the lysosome through an invagination or deformation of the lysosome membrane (94). 
The distinct feature of microautophagy is that invagination or protrusion of the lysosomal 
membrane is used to trap cargo (95). The cargo uptake occurs directly at the membrane of the 
lysosome, and also includes intact organelles. CMA has been best described in mammalian 
cells and is highly specific for engulfing bulk cytoplasm. CMA uses chaperones to identify cargo 
proteins which present a particular pentapeptide motif, and these substrates are then unfolded 
and translocated directly across the lysosomal membrane (96). Of the three primary types of 
autophagy, macroautophagy is the best studied. Unlike microautophagy and CMA, 
macroautophagy involves sequestration of the cargo from an intermediate organelle, a double-
membrane vesicles-autophagosomes, and subsequent transport to the lysosome (97). The 
three major types of autophagy are summarized in Figure 2.2. 
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Figure 2.2: Three major types of autophagy in mammalian cells. Microautophagy involves direct 
update of cargo through invagination or protrusion of the lysosomal membrane. Chaperone-
mediated autophagy transports specific unfolded proteins directly across the lysosomal 
membrane. And macroautophagy utilizes autophagosome to form a cargo and subsequently 
fuse with lysosome to initiate degradation process. Adapted from Parzych, et al. (98). 
 
The most well-studied autophagy process, macroautophagy occurs at low levels but at a 
constant rate in mammalian cells and can be further induced under stress conditions, including 
nutrient or energy starvation, to degrade cytoplasmic material into metabolites which can be 
used in other biosynthetic processes or energy production, which supports cell survival (97). 
The major steps of macroautophagy machinery include induction, nucleation elongation and 
autophagosome completion and fusion. In mammalian cells, autophagosome formation is 
initiated at multiple sites throughout the cytoplasm rather than at a single phagophore assembly 
site (99, 100). After initiation, a phagophore begin to form, which is a primary double-membrane 
sequestering compartment (101). The phagophore will ultimately generate a spherical 
autophagosome. The factors that drive the formation of autophagosome through nonspecific 
macroautophagy are unknown. Compared to nonselective autophagy, selective 
macroautophagy recognizes, wraps around the specific cargo and adjusts to fit the target (102). 
Once the autophagosome is generated, it will deliver its cargo to the lysosome. The lysosome 
will fuse with the lysosomal/vascular membrane in autophagosome, forming the autolysosome 
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(93). Within the autolysosome, acidic lumen and hydrolases help to degrade the cargo and the 
metabolites are exported back to the cytoplasm for use by biosynthetic process or to generate 
energy (97). A schematic model of the autophagy process is summarized in Figure 2.3. 
 
Figure 2.3: A schematic model of the autophagy process. Nutrient stress caused by decreased 
extracellular nutrients or block in nutrient uptake results in decreased intracellular nutrients, 
which triggers macroautophagy process. Macroautophagy occurs in consecutive steps and 
forms autophagosome, which fuses with the lysosome to degrade cytoplasmic components 
including amino acids, fatty acids and et al. The metabolites then are used to undergo 
biosynthesis and energy production. Adapted from Levine (103). 
 
Regulation of autophagy 
The regulation of autophagy primarily occurs at the post-translational level, and as for most 
molecular pathways, immediate transcriptional and translational regulation is the key to 
temporally controlling autophagy when it is required. In response to nutrient and environmental 
stress, several signaling molecules and cascades modulate autophagy (104, 105). Among these, 
the most well-characterized regulator of autophagy is mTOR complex 1 (mTORC1). The 
mTORC1 negatively regulates autophagy by inhibiting the Atg1 (ULK1) complex via direct 
phosphorylation. Additionally, mTORC1 can be inhibited in response to amino acid limitation, 
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reduced growth factor signaling and others, which ultimately results in the induction of 
autophagy (104). During autophagosome formation through the generation of the Atg12-Atg5, 
and Atg8-phosphatidylethanolamine (PE) conjugates, the mTOR-dependent phosphorylation of 
the ULK1 complex and the ubiquitination-like reactions are substantial. Additionally, proteins 
linked to the Atg machinery are substrates for a wide range of post-translational modifications 
including phosphorylation, ubiquitination and acetylation (106). ULK1 is directly phosphorylated 
by the AMP-activated protein kinase (AMPK) in response to energy restriction (107, 108). 
Moreover, AMPK induces autophagy through positively regulation of the Atg1/(ULK1) complex 
and inhibition of mTOR (105). 
The phosphatidylinositol-3-OH kinase (PI3K) complex I also contributes to the induction 
of autophagy. One of the subunits of PI3K complex I, Beclin 1 is necessary to simulate Ptdlns3P 
synthesis, which is associated with other proteins including Bcl-2, 14-3-3 or the intermediate 
filament protein vimentin 1 (VMP1). Additionally, phosphorylation of Beclin 1 by Akt and protein 
kinase B inhibits autophagy through favoring the interaction of Beclin1 with 14-3-3 and VMP1 
(109). Moreover, LC3-II can also be regulated through phosphorylation by ULK and PI3K kinase. 
Phosphorylation of LC3 by PKA or protein kinase C (PKC) impairs LC3 interaction with 
autophagosome and result in incomplete autophagosome (110, 111). The acetylation of Atg is 
also a major point of regulation for autophagy. In the case of nutrient-rich media, Atg5, Atg7, 
LC3 and Atg12 are acetylated by the p300 acetyltransferase in cells and deacetylated by Sirt1 
in response to nutrient starvation (112). Additionally, the acetylation of Atg3 by the Esa1 
orthologue TIP60 in mammals has been shown to promote the interaction between Atg3 and 
Atg8, which is required for Atg8 lipidation (113).  
In addition to being modulated at the post-translational level through mTORC1 signaling, 
the process of autophagy could be regulated at the transcriptional level in response to amino 
acid availability. Amino acid limitation activates GCN2, a sensor of amino acid status in the cell 
and has been shown to induce mRNA expression of autophagy-related genes through 
eIF2α/ATF4 axis in mouse MEF cells (6). Furthermore, we show that mRNA expression of 
autophagy-related genes is activated potentially through increased ATF4 binding in the skeletal 
muscle of rat dams after protein restriction during gestation, which is also associated with an 
induction of mRNA expression of autophagy-related genes in skeletal muscle of male offspring 
(81). A schematic model of transcriptional regulation of autophagy is shown in Figure 2.4. 
Additionally, amino acid deprivation triggers translocation of TFEB, a master regulator of 
lysosomal biogenesis from lysosome into the cell nucleus, resulting in enhanced transcription of 
autophagy-related and lipid catabolism-related genes including PPARα and PGC1α (114, 115). 
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Moreover, the transcriptional activation of a transcription factor FOXO1 through deacetylation by 
sirtuin-1 has been shown to mediate autophagy by glucose deprivation in cardiac myocytes 
(116). 
 
Figure 2.4: A schematic model of transcriptional regulation of autophagy in skeletal muscle. 
Protein limitation during pregnancy increased phosphorylation of eIF2alpha, which activates 
ATF4 and results in increased transcription of Amino Acid Response-related genes and 
autophagy-related genes in the skeletal muscle of rat dams. Adapted from Wang, et al. (81). 
	   
Autophagy and energy metabolism  
Autophagy involves the degradation of unnecessary or dysfunctional cellular components 
through the lysosomal machinery, and has been highly associated with myopathy in skeletal 
muscle (117, 118). LC3 and BNIP3 have been shown to be key proteins during the process of 
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autophagy (119), and ATF4, the key regulatory protein within the AAR pathway that has a role 
in muscle dystrophy induced by fasting (120, 121), has also recently been associated with 
autophagy (6, 120). Due to the well-characterized and direct relationship between protein 
restriction (even marginally) and the activation of ATF4 target genes, the AAR pathway has 
served as a hallmark marker of dietary protein deficiency. However, skeletal muscle accounts 
for over 40% of body protein and is a critical site for labile protein in response to nutritional 
stress, and the autophagic/lysosomal pathway has also been associated with protein 
mobilization in skeletal muscle (122). Therefore, autophagy could potentially serve as an 
additional nutrient-sensing mechanism in response to protein deficiency.  
Microtubule-associated Protein 1 A/B Light Chain 3 (LC3) is a primary maker of 
autophagosomes (123). Rat LC3 has two different variants, LC3A and LC3B, which are both co-
localized with LC3 and are both autophagosome markers (124). The initiation of autophagy is 
highly associated with lipid droplet formation surrounding MAP1LC3 in mouse hepatocytes (125, 
126). It has also been shown that the inhibition of autophagy increases triglyceride storage in 
cultured hepatocytes and mouse liver (126). While the precise mechanism behind the initiation 
is unclear, Map1lc3 and Bnip3, autophagy related genes, appear to be activated at the 
beginning of starvation in the mouse muscle and liver (119, 127). Therefore, as previously 
discussed, a LP diet has been shown to activate several amino acid restriction-related pathways 
such as AAR, ER stress, mTOR and autophagy related pathway, but no studies are available 
showing the role that autophagy may potentially play in the maternal metabolic adaptation to 
protein deficiency during pregnancy and lactation. A low protein diet during pregnancy and 
lactation favors lipid synthesis in liver (4) and LC3B is related to hepatic lipid metabolism (125). 
A schematic model of hepatic lipid metabolism as it is regulated by autophagy by protein 
restriction during pregnancy and lactation is shown in Figure 2.5. 
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Figure 2.5: A schematic model of hepatic lipid metabolism as it is regulated through autophagy 
by protein restriction during pregnancy and lactation. Protein limitation decreases mRNA 
expression of hepatic HDAC3, which is potentially involved in transcriptional activation of LC3b. 
LC3B protein expression is induced which potentially induces autophagy and causes hepatic 
degradation of MTTP and ApoB, two key proteins in hepatic VLDL synthesis.  Decreased VLDL 
export causes accumulation of hepatic TG and ultimately leads to hepatic lipid accumulation. 
Adapted from Wang et al. (unpublished data). 
 
2.4 Maternal Programming and Epigenetics 
Epigenetic mechanisms play an important role in regulation of transcription and potentially 
influence long-term health. Maternal programming through epigenetics occurs at the early stage 
of development., and metabolic disorders including obesity, diabetes, cardiovascular disease 
and hypertension have been shown to be associated with nutritional or environmental 
exposures at early stages of development (128). Therefore, unraveling the relationships 
between maternal programming and epigenetics is imperative for the prevention or treatment of 
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metabolic disorders caused by nutritional or environmental stresses during gestation and 
lactation.  
 
Overview of epigenetics 
Disruption of either the DNA sequence or epigenetic marks on genes results in abnormal mRNA 
expression, which is why these are considered to be the fundamental mechanisms underlying 
disease development. Additionally, epigenetic regulation is one of the key contributors to 
developmental plasticity in response to nutritional and environmental stimuli (129, 130). In 
recent years, numerous epigenetic mechanisms have been studied intensively, including DNA 
methylation (131), histone modifications (132), small and non-coding RNAs (133), and 
chromatin architecture (134). DNA methylation and histone modifications are the two most-
studied epigenetic modifications associated with developmental maternal programming. A 
schematic diagram of epigenetic modifications is shown In Figure 2.6. 
DNA methylation is especially sensitive to perturbations at the early stages of 
development, and most likely results in life-long and possibly trans-generational outcomes (135), 
and chromatin states that arise during this period can further affect the propensity to subsequent 
epigenetic changes. This is evident in the predisposition of stem cells that contain polycomb-
repressive complex occupied genes to acquire DNA methylation abnormalities in aging and 
cancer (136) (137-139). In 1975, DNA methylation was proposed to be responsible for the 
stable maintenance of gene expression through mitotic cell division (140, 141). Since then, 
numerous studied proved this concept and DNA methylation is now recognized to be one of the 
primary contributors to the stability of gene expression. DNA methylation is a post-replication 
modification, which is predominantly found in cytosines of the CpG dinucleotide sequence sites. 
During mammalian development, demethylation occurs during DNA cleavage, followed by 
genome-wide de novo methylation following implantation (142). Specifically, a silent chromatin 
state is established by DNA methylation through blocking transcription and collaborating 
proteins, which modify nucleosomes (143). Mechanism that regulate DNA methylation and the 
establishment of methylation patterns during development have been shown to be associated 
with various DNA methyltransferase (DNMT) genes (131). Deletion of Dnmt1 in mice results in 
global demethylation and embryonic lethality (144, 145), while Dnmt3a and Dnmt3b are highly 
expressed in the developing mouse embryo and are responsible for global de novo 
demethylation after implantation (146).  
Unlike DNA methylation, histone tails can be modified in multiple ways, including 
acetylation, methylation and phosphorylation (147). Acetylation of histones at lysine residues is 
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catalyzed by histone acetyltransferases (HATs), and is associated with the activation of gene 
transcription. Deacetylation of histones is associated with the silencing of transcription, and is 
catalyzed by histone deacetylases (HDACs) (148). Overall, the acetylation of histones marks 
active transcriptionally competent regions, while hypoacetylated histones are found in 
transcriptionally inactive euchromatic or heterochromatic regions. Histone methylation regulates 
gene transcription depending on the site of modification. Methylation of lysine 9 on the N 
terminus of histone H3 (H3K9Me) is typically a hallmark of silent DNA and is globally distributed 
throughout heterochromatic regions such as centromeres and telomeres (149). However, 
methylation of lysine 4 of histone 3 (H3K4Me) activates gene transcription and is primarily found 
in promoter regions (149). Lysine can be modified by mono-, di- and trimethylation. The 
enormous variation is thus likely to result in a diversity of possible combinations of different 
modifications.  
 
Figure 2.6: A schematic diagram of epigenetic modifications. Two primary epigenetic 
modifications (DNA methylation and histone modification) are shown in the figure. DNA 
methylation occurs directly on the DNA strand, while histone modification happen on histone 
tails. Five major types of histone modifications include acetylation (Ac), methylation (Me), 
sumoylation (S), phosphorylation (P), and ubiquitination (Ub). Adapted from Qiu (150) and 
Strakovsky (151).  
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Epigenetic characteristics of maternal programming  
Epigenetic changes are sensitive readouts of the consequences of acute and chronic exposures 
to environmental factors. They greatly rely on dose, duration, and life-stage at the time of 
exposure. More particularly, intense effects are usually found during the susceptible window of 
fetal development (152), thus exposure to environmental factors during certain developmental 
stages will strongly influence disease etiology. During sensitive windows, differentiation of cells 
and organ systems are susceptible to programming. Consequentially, altered programming and 
gene expression due to environmental factors can lead to abnormal physiology and disease in 
adult life (153). Therefore, it is reasonable to assume that environmental factors predispose 
phenotypic changes or disease progression, and this is not limited only to the individual 
exposed, but also includes subsequent generations. Normally, exposure to mild environmental 
factors such as nutrients, toxicants, or endocrine disruptors, are insufficient in and of 
themselves to produce genetic mutations, but can also produce alterations in the epigenome, 
which are known as epimutations (153). 
In recent studies, a maternal high fat diet has been shown to induce DNA 
hypomethylation in the brain of mouse offspring (154). Our lab has also demonstrated that a life-
long high fat diet (in utero through adulthood) influences genome-wide differential DNA 
methylation patterns in the liver of male rat offspring (155). Furthermore, we have shown that a 
maternal high-fat diet alters histone modifications at the promoter of the Pon1 gene, an 
important antioxidant enzyme, in livers of neonatal rats (156). A summary of maternal dietary 
programming and epigenetic modifications is shown in Table 2.4. 
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Table 2.4: Maternal dietary programming and epigenetic modifications. Adapted from 
Strakovsky and Pan (151), refer to the original review for the full list of references.  
 
 
Autophagy and epigenetics  
Accumulating evidence has shown that autophagy is regulated by histone-modifying proteins. 
Study of HDAC inhibitors was the first attempt to link autophagy to histone modifications which 
promote histone acetylation and thereby affect gene expression. In 2004, Shao et al. showed 
that butyrate and suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor, induced 
autophagy in HeLa cells (10). HDAC inhibitors influence the global acetylation levels within the 
cell and play a role in the regulation of autophagy (113, 157, 158). However, acetylation of 
specific histone tails is the key player in the regulation of autophagy and has been studied 
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intensively in the last decades. Histone H3 acetylation on Lys 9 and 14 was shown to be 
induced by the inhibition of histone acetyltransferase (HAT), resulting in induced autophagy-
related gene expression, including Atg7, Atg11 and Atg15, and leads to decreased oxidative 
stress and increased longevity in aging yeast (159). Additionally, maintenance of functional 
autophagy requires a NAD-dependent deacetylase (Sirt1), absence of which acetylates 
autophagy related proteins including Atg5, Atg7 and Atg8 in mice (160). Moreover, repression of 
p300 acetyltransferase is critical for maintaining starvation-induced autophagy, and p300 
acetyltransferase acetylates autophagy related proteins including Atg5, Atg7, Atg8 (Map1lc3) 
and Atg12 in mice (112). Acetylation of histone H4 lysine 16 (H4K16Ac) modulates functional 
interactions between histones and the chromatin, providing a potential regulatory mechanism for 
chromatin folding and transcriptional regulation. Genome-wide deacetylation of H4 lysine 16 is 
primarily associated with down-regulation of autophagy-relate genes including Atg9a, Map1lc3, 
Ulk1 and Ulk3, in turns, regulates autophagic flux (161). Induction of autophagy down-regulates 
KAT8, which contributes to decreased acetylation of H4 lysine 16. Di- and tri-methylation of 
histone H3 on Lysine 4 (H3K4Me2/3) is potentially involved in transcriptional activation. It has 
also been recently reported that the WNT/β-catenin signaling pathway negatively regulates 
autophagy by inhibiting the transcription of p62. During nutrient deprivation, β-catenin is 
released from the p62 promoter and degraded, which coincides with increased acetylation of 
histone H3, thus resulting in increased transcription of p62 and autophagy levels (162). As a 
result, the degradation of β-catenin through autophagy is potentially involved in the down-
regulation of H3K4Me3 levels. Another important histone modification regulating autophagy is 
the dimethylation of Lysine 9 on histone H3 (H3K9Me2). Recently, it has shown that inhibition of 
methyltransferase G9a removes H3K9Me2 from the promoters of several autophagy-regulated 
genes, resulting in the induction of autophagy in vitro (163). The increase of H3K9Me2 depends 
on the decrease of H3K9 acetylation. During the induction of autophagy, p62 leaves the 
promoter region of LC3b, allowing for demethylation of H3K9Me2 as well as acetylation of H3K9 
and resulting in increased expression of autophagy-related proteins (163).  
Furthermore, autophagy is potentially associated with DNA methylation. Studies on the 
regulation of autophagy by DNA methylation have been primarily performed in cancer cells. The 
mRNA expression of Beclin1, an autophagy-related gene is decreased in breast tumors, 
coinciding with increased DNA methylation on the promoter and intron 1 of Beclin1 (164).  In 
glioblastoma, DNA methylation of ULK2, an upstream marker of autophagy, decreases the 
gene’s mRNA expression, which is required for tumor growth (165). The various studies on 
epigenetic regulation of autophagy are summarized in Table 2.5. 
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Table 2.5: The relationship between epigenetic modifications and the regulation of autophagy 
Experimental model Epigenetic modification Evidence of autophagy Physiological outcomes References 
Hela cell lines ↑acetylations by HDAC inhibitors ↑Autophagosome formation  
Caspase independent autophagic 
cell death 
Shao, et al (10) 
Yeast, flies, worms and 
human cells 
↓HAT, ↓ histone H3 lys 9 and 14 
acetylation by spermmidine 
↑autophagy-related gene 
expression including Atg7, Atg11 
and Atg15 
↓ oxidative stress and necrosis and 
↑ longevity 
Eisenberg, et al 
(159) 
Mouse embryonic 
fibroblasts 
↑acetylation by absence of Sirt1  
↓autophagy, ↑ acetylation of Atg5, 
Atg7 and Atg8, ↑ levels of p62 
↑accumulation of abnormal 
organelles includes mitorchondria 
Lee, et al (160) 
Hela cell lines ↑ acetylation by p300 acetyltransferase 
↑acetylation of Atg5, Atg7, Atg8 
and Atg12; ↓conversion of LC3-I to 
LC3-II, ↑p62 protein expression 
↓ starvation-induced autopahgy 
Lee and Finkel 
(112) 
Mouse embryonic 
fibroblasts 
Autophagy ↓ acetylation of histone H4 
lys 16;↓genome-wide acetylation of 
histone H4 lys 16 inhibit autophagy-
related gene expression 
↓genome-wide acetylation of 
histone H4 lys 16 promotes cell 
death 
maintain proper autophagy, 
disturbance results in cell death 
Füllgrabe, et al. 
(161) 
Colon cancer cells 
Nutrient deprivation ↑ acetylated histone 
H3 on p62 promoter, results in ↑ 
transcription of p62 
↑Autophagosome formationm; 
conversion of LC3-I to LC3-II; ↑ 
p62 expression  
Autophagy degredated β-catenin 
and inhibit WNT signaling pathway, 
impair tumor development 
Petherick, et al. 
(162) 
Hela cell lines and 
pancreatic SU86.86 
cells 
Repression of methyltransferase G9a ↓ 
H3K9Me2, ↑ H3K9Ac and PolII binding 
on the promoter of LC3b 
Repression of methyltransferase 
G9a ↑autophagosome formation 
and conversion of LC3-I to LC3-II  
G9a negatively regulates 
autophagy, an important cell 
survival process 
Artal-Martinez 
de Narvajas, et 
al. (163) 
Human breast tumors 
DNA methylation on the promoter and 
intron 2 of Beclin 1 
↓mRNA and protein expression of 
Beclin1 
Beclin1 is inversely correlated with 
breast tumors 
Li, et al (164) 
Glioblastoma  
DNA methylation on ULK2, an upstream 
autophagy initiator 
↓ULK2 expression, conversion of 
LC3-I to LC3-II 
ULK2 ↑ autophagy and ↓ 
glioblastoma growth 
Shukla, et al 
(165) 
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CHAPTER 3 
INDUCTION OF AUTOPHAGY THROUGH ATF4-DEPENDENT AMINO ACID RESPONSE 
PATHWAY IN MATERNAL SKELETAL MUSCLE IN RESPONSE TO GESTATIONAL 
PROTEIN RESTRICTION MAY ACT AS THE MOLECULAR MEMORY TO ALERT 
OFFSPRING OF THEIR POSTNATAL ENVIRONMENT1 
3.1 Abstract 
To investigate the mechanistic basis of how the gestational maternal protein deficiency signal is 
transduced to the offspring, timed-pregnant Sprague-Dawley rats were fed either a control 
(Control, 20% protein) or low protein (LP, 8% protein) diet during gestation. Skeletal muscle, 
liver, adipose and blood were collected after natural delivery in rat dams and skeletal muscle 
was collected at postnatal day 38 in offspring. Quantitative RT-PCR and Western blot analyses 
were performed to determine skeletal muscle mRNA and protein levels. Histology analysis was 
performed to evaluate myofiber size. LP dams gained significantly less weight during pregnancy, 
developed muscle atrophy, and had significantly lower circulating threonine and histidine levels 
than control dams. mRNA expression of Amino Acid Response (AAR) pathway-target genes, 
including Asns, Atf3 and Chop was up-regulated only in skeletal muscle of LP dams, as were 
ATF4 and p-eIF2alpha protein levels. mRNA expression of autophagy-related genes, including 
LC3a, LC3b, Atg4b and Bnip3 genes was significantly up-regulated in LP dams. Moreover, both 
the AAR and autophagy pathways remained activated and memorized in the muscle of offspring 
of which LP dams consumed a post-weaning control diet. Furthermore, LP diet increased LC3B 
protein in the skeletal muscle of rat dam, consistent with initiation of autophagy. The LP diet 
further increased ATF4 binding on the predicted regions of AAR genes, as well as Lc3a, Lc3b, 
Atg4b and Bnip3. Increased binding of ATF4 unveils the potential role of ATF4 in the activation 
of autophagy in response to protein restriction. Our data suggest that molecular changes in 
maternal muscle are memorized in offspring long after gestational protein restriction, reinforcing 
the role of maternal signaling in programming offspring health.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  This chapter is part of published the published manuscript: “Wang H, et al. Induction of autophagy through the 
activating transcription factor 4 (ATF4)-dependent amino acid response pathway in maternal skeletal muscle may 
function as the molecular memory in response to gestational protein restriction to alert offspring to maternal nutrition. 
Br J Nutr. 2015 Jul 22:1-14. [Epub ahead of print]”.	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3.2 Introduction 
During pregnancy, maternal macronutrient metabolism changes to adapt to the needs of the 
developing fetus (24). Although changes in glucose metabolism occur in parallel with increasing 
energy demands, adaptation of protein metabolism – through the accumulation and breakdown 
of protein stores – is an essential component of the maternal adaptation to pregnancy (20). 
Pregnancy is often associated with hypoaminoacidemia and urinary nitrogen losses during 
fasting, which is evident early in gestation and persists throughout pregnancy (21, 22). The 
major source of urea nitrogen during pregnancy is peripheral (muscle) release of amino acids 
(20), and Kalkhoff, et al. showed a positive correlation between total circulating amino acid 
concentrations and neonatal birth weight (23). The role of maternal protein balance in both 
maternal health and gestational outcomes highlights the importance of the maternal diet. 
Because of this, the low-protein (LP) rodent model is one of the best-characterized 
developmental programming models, demonstrating that even a marginal protein restriction (8% 
protein) during pregnancy has physiological impacts both for the mother and offspring (166).  
Dietary protein restriction in experimental animals and cell culture models produces 
numerous metabolic responses, including activation of the Amino Acid Response (AAR) 
pathway (167). AAR pathway activation in response to amino acid limitation occurs largely 
through signal transduction mediated altered transcriptional activity of specific genes including 
Asns (71), Atf3 (72) and Chop (168, 169). Activation of the AAR pathway requires 
phosphorylation of the eukaryotic translation initiation factor 2 alpha (eIF2alpha) by GCN2 
kinase leading to the decrease of global protein synthesis (170) but an increase in the synthesis 
of ATF4 protein (170-172), which activates multiple stress-induced genes, including genes 
containing an amino acid response element (AARE) (78). Therefore, ATF4 appears to serve as 
a master regulator of the AAR pathway, further supported by observations that ATF4 binds at 
the Asns (79) and Atf3 (80) promoter regions.  
Due to the well-characterized and direct relationship between protein restriction (even 
marginally) and the activation of ATF4 target genes, the AAR pathway has served as a hallmark 
marker of dietary protein deficiency. However, skeletal muscle accounts for over 40% of body 
protein and is a critical site for labile protein in response to nutritional stress, and the 
autophagic/lysosomal pathway has also been associated with protein mobilization in skeletal 
muscle (122). Therefore, autophagy could potentially serve as an additional nutrient-sensing 
mechanism in response to protein deficiency. Autophagy, primarily known as macroautophagy 
in cellular metabolism, involves cell degradation of unnecessary or dysfunctional cellular 
components through the lysosomal machinery, and has been highly associated with myopathy 
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(173, 174). LC3 and BNIP3 have been shown to be key proteins during the process of 
autophagy (119), and ATF4, the key regulatory protein within the AAR pathway that has a role 
in muscle dystrophy induced by fasting (175, 176), has also recently been associated with 
autophagy (6, 120). 
Gestational protein restriction activates the placental AAR pathway, which is associated 
with long-term growth restriction in the offspring (50). However, the response and potential 
contribution of maternal metabolism in this process is unknown. Therefore, the purpose of the 
present study was to investigate the molecular response of maternal tissues to gestational 
protein restriction. Specifically, we first focused on the AAR pathway as the classic marker of 
protein restriction, and then investigated the potential role of ATF4 within the autophagy 
pathway, as a potential physiological consequence of gestational protein deficiency. We also 
relied on our study in which gestationally LP diet-exposed offspring were growth-restricted 
adults, despite consuming a control diet after weaning, to determine whether gestational protein 
restriction was still evident at the molecular level in the muscle of these offspring at postnatal 
day 38. Understanding the adaptations that occur within maternal metabolism in response to 
protein restriction would provide valuable insight into our understanding of how the maternal 
tissue/placental/fetal axis contributes to the programming of chronic diseases in response to 
maternal protein limitation. 
3.3 Material and Methods 
Animals and diets 
Timed-pregnant Sprague-Dawley rats were obtained from Charles River Laboratories (Charles 
River Laboratories, Wilmington, MA) and randomly assigned to one (n=6) of two isocaloric, 
modified AIN-93 diets (177) (Research diet Inc., New Brunswick, NJ; Table 3.1). Study 1: 
control diet (Control; 20 % protein, 64 % carbohydrate and 16% fat) or low protein diet (LP; 8 % 
protein, 76 % carbohydrate, and 16% fat) from day 2 of gestation until the end of gestation; 
Study 2: control diet (Control; 18 % protein, 66 % carbohydrate and 16% fat) or low protein diet 
(LP; 9 % protein, 75 % carbohydrate and 16% fat) from day 2 of gestation until the end of 
gestation(50). Rat dams in Study 2 consumed a control diet during lactation (50, 178), and all 
offspring consumed the same control diet after weaning (postnatal day 21) until postnatal day 
38. Animals were housed individually in standard polycarbonate cages in a humidity- and 
temperature- controlled environment on a 12-h light-dark cycle. Body weights and food intake 
were recorded every-other day.  
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Post-delivery dams were fasted for 8 h and then euthanized by carbon dioxide for 20 s 
before being decapitated to collect blood for plasma and serum. Visceral adipose tissue, 
gastrocnemius muscle and liver samples from dams in Study 1 were harvested and snap frozen 
in liquid nitrogen and stored at -80 °C for future analyses. Skeletal muscle from offspring was 
collected on 38 days after birth in Study 2. All experiments were conducted in accordance with 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals (179) and 
were approved by the University of Illinois at Urbana-Champaign Institutional Animal Care and 
Use Committee.  
 
Plasma measurements 
Maternal plasma obtained from trunk blood was immediately centrifuged at 800 x g for 20 min at 
4 °C. Plasma samples were stored at -70 °C until further analysis. Plasma free amino acid 
concentrations were measured by HPLC using a Waters 2475 Fluorescence Detector (180). 
Amino acid Hydrolysate standard was purchased from the same company (WAT088122). 
Analyses included essential amino acids: Leu, Ile, Lys, Met, Val and Thr and nonessential 
amino acids: His, Glu, Asp, Pro, Tyr, Ala, Arg, Ser and Gly. 
 
Muscle fiber diameter  
Six frozen muscle samples from each treatment group were embedded in Tissue-Tek OCT 
compound (VWR, Radnor, PA) and cut to 5 µm thickness cross-sectionally using a Leica 
CM3050 S cryostat (Leica Microsystems Inc., IL) at -20 °C, procedure was as reported (181, 
182). All sections were fixed in 70% ethanol and stained with hematoxylin and eosin (H&E) 
(Newcomer Supply). Histopathological examination was blindly performed using light 
microscopy by a certified pathologist, Dr. S. L. Slides were scanned using a Nanozoomer Digital 
Pathology System with the magnification of 20X (Hamamatsu Photonics K.K., Japan), and 
image analysis was performed using ImageJ software. Three independent regions from each 
section were selected for quantification. The diameters of at least 60 myofibers per independent 
region were measured using the lesser diameter method as previously described (121). 
 
RNA isolation and two-step real time quantitative PCR (qPCR) 
Total RNA was isolated from visceral adipose tissue, gastrocnemius muscle, liver and blood in 
dams, and from gastrocnemius muscle in offspring using Tri-reagent (Sigma-Aldrich, St. Louis, 
MO) according to the manufacturer’s instruction. RNA concentration was analyzed by a Bio-Rad 
spectrophotometer (Bio-Rad laboratories Inc, Irvine, CA) at 260 nm. Total mRNA (2 µg) was 
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used for cDNA synthesis by High Capacity cDNA Reverse transcription Kit (Applied Biosysterms, 
Foster City, CA) with a DNA 2720 Thermal Cycler (Applied Biosystems, Foster City, CA). The 
program was as follows: 25 °C for 10 min, 37 °C 
 for 120 min, and 85 °C for 5 sec. After synthesis, 25 ng of cDNA was analyzed using 
quantitative real-time PCR and gene expression was assessed using the 2x Perfecta SYBR 
Green fast master mix (Quanta BioSciences, www.vwr.com) with a 7300 real-time PCR system 
(Applied Biosystems, Foster City, CA). Primer sequences used in the experiment are listed in 
Table 3.2, and were designed by Vector NTI software (Invitrogen Corporation, Carlsbad, CA) 
and synthesized by Integrated DNA Technologies (www.idtdna.com). Reaction was as follows: 
95 °C for 15 min, 95 °C for 15 s and 60 °C for 60 s in 40 cycles. After amplification, dissociation 
curves were acquired by stepwise increases from 55 °C to 95 °C to ensure a specific product 
amplified in the reaction. Standard curves with slope of -3.30±0.20 and R2 ≥0.99 were accepted. 
The following tissue-specific housekeeping genes whose expression was not affected by the 
treatment were used to normalize all mRNA data: L7a in rat dams’ adipose tissue and 
in offspring skeletal muscle, Tbp in rat dams’ liver and blood, and beta-actin (Actb) in rat dams’ 
skeletal muscle. 
 
Protein isolation and Western blotting 
Frozen gastrocnemius muscle (200 mg) was ground in liquid nitrogen and suspended in 500 µl 
of protein lysis buffer (0.125 mol/L Tris–HCl, pH 6.8, 1% SDS, 0.04% bromophenol blue, and 20% 
glycerol, v/v) with 1x proteinase inhibitor (Roche applied sciences, Indianapolis, IN) and 
phosphatase inhibitor cocktail 1 and 2 (Sigma-Aldrich, St. Lois, MO). Samples were then 
sonicated with 25 pulses at power setting 2 (Fisher Scientific model 100 Sonic Dismembrator, 
Pittsburgh, PA). Twenty µg of diluted protein was size-fractionated on a 12% Tris–HCl 
polyacrylamide gel and transferred onto a PVDF membrane (Bio-Rad laboratories Inc, Irvine, 
CA) at 0.3 A according to the wet transfer protocol. To investigate ATF4 (CERB-2) protein 
expression, the PVDF membrane was incubated with blocking solution (10% (w/v) nonfat dry 
milk (NFDM)) in TBS/T (20 mmol/L Tris–HCl, pH 7.6, 137 mmol/L NaCl, and 0.1% (v/v) Tween-
20) for 1 h at room temperature. A rabbit polyclonal antibody against ATF4 (sc-200, Santa Cruz, 
CA) was diluted to 1:1,500 in the blocking solution with 10% NFDM and incubated with the 
membrane for 3 h at room temperature before washing with 5% NFDM in TBS/T for 5 x 5 min. A 
goat anti-rabbit HRP-conjugated secondary antibody (Kirkegaard&Perry Laboratories, 
Gaithersburg, MD) was diluted to 1:10,000 in the blocking solution containing 5% NFDM and 
incubated with the membrane for 1 h at room temperature. After washing for 5 x 5 min in the 
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blocking solution containing 3% (w/v) NFDM, the membrane was exposed to the enhanced 
chemiluminescence reagent Super Signal West Dura (Thermo Fisher Scientific, Rockford, IL). 
Signals from the membrane were detected and quantified by the ChemiDoc XRS imaging 
system (Bio-Rad, Hercules, CA). Actin (SC-1616-R, Santa Cruz, CA) was used as a loading 
control for the protein expression of ATF4. Total eIF2alpha (9722S, Cell Signaling Technology, 
Inc., Danvers, MA) was used as a loading control for p-eIF2alpha (9721L, Cell Signaling 
Technology, Inc., Danvers, MA). The condition for detecting p-eIF2alpha protein was as follows: 
5% NFDM in TBS/T solution for 1 h blocking and 1:1,000 diluted primary antibody against p-
eIF2alpha for a 3 h incubation at room temperature. One percent NFDM in TBS/T solution was 
used for washing 5 x 5 min and incubation of secondary monoclonal goat-anti-rabbit antibody 
(Cell Signaling Technology, Inc., Danvers, MA) for 1 h. One percent NFDM in TBS/T was also 
used for the subsequent 5 x 5 min washing.   
 
Chromatin immunoprecipitation (ChIP)  
ChIP analysis was performed according to a modified protocol (79). In brief, 200 mg frozen 
gastrocnemius muscle was ground in liquid nitrogen and suspended in PBS. Protein-DNA 
cross-linking was performed by 1% formaldehyde in PBS solution for 10 min and the reaction 
was stopped by 2 M Glycine to a final concentration of 0.125 M. Nuclei were collected after 
nuclei swelling buffer treatment (5 mmol/L PIPES pH 8.0, 85 mmol/L KCl, 0.5 % NP40) and 
lysed in SDS lysis buffer (50 mmol/L Tris-HCl pH 8.1, 10 mmol/L EDTA, 1% SDS) containing 
protease inhibitor and phosphatase inhibitor cocktails. Cross-linked chromatin was sheered and 
homogenized on ice by a Sonic Dismembrator (model F100, Fisher Scientific, Pittsburgh, PA) 
for 40 s at power setting 5 with 2 min cooling interval between each burst, with total of 5 bursts. 
The average length of sonicated chromatin was ~500 bp and cell debris was removed by 
centrifugation at 13,000 x g for 10 min at 4 °C. Sheared-chromatin was diluted to 10 mL with 
ChIP dilution buffer. One mL of diluted chromatin was incubated overnight with 2 µg antibody at 
4 °C. The chromatin-antibody complex was precipitated with 60 µL of 50% slurry of pre-blocked 
protein G-agarose beads (Millipore, Billerica, MA) for 2 h at 4 °C. A normal rabbit IgG was used 
as a negative control. Supernatant from the incubated IgG was saved as the input DNA for each 
sample. The protein G-agarose beads were sequentially washed with 1 mL each of the following 
solutions: low salt (20 mmol/L pH 8.0 Tris-HCl, 0.1% SDS, 2 mmol/L EDTA, 150 mmol/L NaCl, 1% 
triton X-100), high salt (20 mmol/L pH 8.0 Tris-HCl, 0.1% SDS, 2 mmol/L EDTA, 500 mmol/L 
NaCl, 1% triton X-100), LiCl (10 mmol/L pH 8.0 Tris-HCl, 0.25 mmol/L LiCl, 1% NP40, 1 mmol/L 
EDTA, 1% sodium deoxycholate) and twice with Tris-EDTA (pH 8.0). Antibody/protein/DNA 
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complexes were eluted by 2x 250 µL elution buffer (1% SDS and 50 mmol/L NaHCO3) at 37 °C 
for 15 min each time. Reverse cross-linking was performed with 20 µL of 5 mol/L NaCl and 1 µg 
of RNase A at 65 °C for 5 h. Chromatin DNA was purified using QiaPrep miniprep kit (Qiagen, 
Valencia, CA) after proteinase K digestion. The results were expressed as average–IgG ratio to 
input DNA. Antibodies are listed in Table 3.3. 
 
Bioinformatics  
Transcription factor binding sites were identified by TFSEARCH (183) and MatInspector (184) 
programs. All sequences were derived from the promoter sequence retrieval database 
EIDorado 02-2010 (Genomatix, Munich, Germany). The motif of AARE and CREB were 
scanned with the Gene2promoter large-scale program in the Genomatix software suite GEMS 
Launcher v2.7 to evaluate any genes containing AARE and CREB binding motifs within the rat 
genome (184). The promoter sequences were defined as those predicted in EIDorado and 
elongated at the 3’ end of the promoter (downstream) by 150 bp. Position weight and matrices 
were used according to Matrix Family Library Version 8.2 (Genomatix) (January 2010) for 
promoter analysis (Figure 3. 4A).   
 
Statistical analysis 
Each data point represents the mean ± SEM. Food intake and body weight were analyzed by 
repeated-measures one-way ANOVA (SAS Institute Inc., Cary, NC). Two-way ANOVA was 
used for ChIP data with a Tukey post hoc comparison. Student’s t-test was used for 2-group 
comparisons (Control vs LP) including plasma amino acid concentration, mRNA expression, 
and protein expression. Differences were considered significant at *p<0.05 and **p<0.01. 
Sample size was calculated by statistical power analysis based on a 95% CI using Statistical 
Solutions, LLC (Statistical Solutions, LLC, Clearwater, FL). 
3.4 Results 
A gestational low protein diet reduces weight gain in rat dams 
Pregnant rats consuming a LP diet weighed significantly less than the Control group at days 17, 
19 and 21 of gestation (p<0.01) (Figure 3.1A), but food intake was not significantly different in 
LP rat dams compared to Control (Figure 3.1B). Gestational weight gain was significantly lower 
in the LP group when compared to control (p<0.01, Figure 3.1C). The litter sizes were not 
different between Control and LP group. The birth weight of LP offspring was significantly lower 
(p<0.05, Figure 3.1D) when compared to control. However, even after taking offspring birth 
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weight into consideration, net gestational weight gain (after subtracting pup birth weight) 
remained significantly lower in LP dams when compared to controls (p<0.01, Figure 3.1E).  
A gestational low protein diet alters the plasma amino acids profile in rat dams  
At the end of pregnancy, circulating Thr and His were significantly lower (p<0.05) in LP dams 
when compared to controls (Table 3.4). Lys, Ala and Ser were significantly higher (p<0.05) in 
the LP group, while Leu, Ile, Lys, Met, Val, Glu, Asp, Pro, Tyr, Arg and Gly did not differ 
between groups (Table 3.5).  
 
A gestational low protein diet induces skeletal muscle atrophy in rat dams  
Muscle consists of bundles of multinucleated cells, called muscle fibers, or myofibers, which 
were assessed in rat dams after delivery using H&E. A gestational LP diet has been reported to 
alter mechanical properties of skeletal muscle in male offspring (185), but the consequences for 
the dam have not been reported. We observed more varied sizes of muscle fibers, splitting 
muscle fibers, and clustered basophilic fibers in the skeletal muscle of the LP group when 
compared to the control (Figure 3.2A) after delivery. Fibers in the size range of 46-65 µm were 
decreased in the LP group when compared to control (p<0.05), whereas the LP group had more 
fibers in the size range of 66-91 µm when compared to control (Figure 3.2B). Overall, the 
gestational LP diet caused a more varied distribution of fiber diameters compared to Control 
group (Figure 3.2C) in the skeletal muscle of dams. Furthermore, the gestational LP diet 
significantly decreased the overall average skeletal muscle fiber size in rat dams (Figure 3.2D), 
which has previously been associated with myopathy (5, 120, 121).  
 
A gestational low protein diet induces AAR pathway target genes in skeletal muscle of rat dams  
The impact of gestational protein restriction on the AAR pathway was assessed by investigating 
the mRNA expression of AAR downstream genes (Asns, Atf3 and Chop) in visceral adipose 
tissue, gastrocnemius (skeletal) muscle, liver and blood of rat dams after delivery. A gestational 
LP diet induced the mRNA expression of Asns (2-fold, p<0.05), Atf3 (1-fold, p<0.05) and Chop 
(1.5-fold, p<0.05) when compared to control diet in skeletal muscle (Figure 3.3A) but not in 
other tissues (Figure 3.3B). These results show that a gestational low protein diet induces a 
tissue-specific response of AAR downstream genes in rat dams. 
 
A gestational low protein diet increases ATF4 protein expression and eIF2alpha phosphorylation 
as well as ATF4 binding at the promoter of AAR genes in skeletal muscle of rat dams  
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To confirm the activation of the AAR pathway, whole cell p-eIF2alpha and ATF4 protein 
abundance were analyzed in skeletal muscle from dams after delivery (Figure 3.4A and Figure 
3.4B). Phosphorylation of eIF2alpha on Ser 51, an upstream event required for the activation of 
the AAR pathway, was higher in skeletal muscle of the LP group when compared to control 
(Figure 3.4A and 3.4B), and muscle ATF4 protein expression was significantly higher in LP 
dams when compared to control (Figure 3.4A and 3.4B). Based on the observed increased 
mRNA expression of ATF4 target genes, we investigated the binding of ATF4 at the promoter 
regions of these genes in skeletal muscle of dams after delivery. Overall, the binding of ATF4 
was significantly induced by a gestational LP diet at the predicted regions of the genes 
examined, including Asns (3-fold, p<0.05), Atf3 (1.5-fold, p=0.06) and Chop (4.5-fold, p<0.05) 
(Figure 3.4C), thus confirming the ATF4-induced activation of the AAR pathway in the muscle 
of rat dams at the end of gestation. 
 
A gestational low protein diet increases the mRNA expression of autophagy pathway-related 
genes and LC3B protein expression in the skeletal muscle of rat dams  
The proposed process of cellular autophagy and its relationship with the AAR pathway is 
described in Figure 3.5A (adapted from literature (6, 119, 186)). The mRNA expression of 
autophagy-related genes, including LC3a (1.5-fold, p<0.05,), LC3b (2-fold, p<0.05), Bnip3 (2.5-
fold, p<0.05) and Atg4b (1.4-fold, p<0.05), was significantly induced in dams by a gestational LP 
diet (Figure 3.5B). Further, to confirm the observed activation of autophagy, whole cell LC3B 
protein abundance was analyzed in the skeletal muscle of dams. The protein expression of 
LC3B, which is used as the primary indicator of autophagy, was higher in the skeletal muscle of 
LP dams when compared to the control (2-fold, p<0.05) (Figure 3.5C).  
 
A gestational low protein diet induces the binding of ATF4 on the regions of autophagy-related 
pathways genes predicted by bioinformatics analysis in the skeletal muscle of rat dams 
Based on the increased mRNA expression of autophagy-related genes and the proposed 
relationship between autophagy and AAR, we investigated ATF4 binding at the predicted 
regions of downstream autophagy pathway-related genes in skeletal muscle of dams (Figure 
3.6A). When compared to control, a gestational LP diet in dams increased the binding of ATF4 
at the predicted regions of the autophagy-related genes examined, including LC3a (2-fold, 
p<0.01,), LC3b (2-fold, p<0.05), Atg4b (2.5-fold, p<0.01) and Bnip3 (1.5-fold, p<0.05) from 
(Figure 3.6B). 
 
	  35 
A gestational low protein diet induces the AAR pathway and autophagy pathway related genes 
in the skeletal muscle of male offspring  
Our previous study showed that placenta may sense gestational protein limitation, and this is 
associated with growth restriction in the offspring (50). To investigate whether these previous 
observations and the current observation that maternal skeletal muscle is potentially involved in 
the response to gestational protein limitation, we investigated the mRNA expression of both 
AAR and autophagy-related genes in skeletal muscle of offspring in our previously described 
study. Similar to what was observed in dams at delivery, the gestational LP diet significantly 
induced the mRNA expression of Asns (2-fold, p<0.01), Atf3 (5-fold, p<0.05) and Chop (2-fold, 
p<0.01) in male, but not female skeletal muscle (Figure 3.7A). Furthermore, and also similar to 
what was observed in the dam, the mRNA expression of autophagy-related genes, including 
LC3a (3-fold, p<0.05), LC3b (5-fold, p<0.01), Atg2a (2-fold, p<0.05) and Atg4b (4-fold, p<0.05), 
was significantly induced by a gestational LP diet in male, but not female skeletal muscle 
(Figure 3.7B).  
3.5 Discussion 
To our knowledge, this study is the first to demonstrate the following novel mechanisms: First, a 
gestational LP diet alters the maternal plasma amino acid profile, together with decreased 
maternal and pup body weights and apparent muscle dystrophy in the dam at delivery in an in 
vivo rat pregnancy model. Second, the LP diet produced tissue-specific activation of AAR and 
autophagy pathway genes in maternal skeletal muscle, but not in liver, blood or adipose. Third, 
the LP diet increased the binding of ATF4 within specific autophagy-related target genes, 
confirming a molecular link between activation of the AAR signal and the autophagy pathway. 
Together, these data, as well as follow-up data from our previous study showing that a gestation 
LP diet also activates AAR and autophagy genes in the skeletal muscle of male offspring, 
provide insight into the transduction of the gestational amino acid limitation signal from maternal 
muscle, to placenta (50), and to the offspring. A proposed schematic diagram highlights the 
mechanism that a gestational low protein diet programed offspring growth capacity through 
signal transduction from skeletal muscle of rat dam (Figure 3.8). Furthermore, the molecular 
mechanisms described in this study provide novel insight into the role of ATF4 in activating 
critical autophagy genes in the skeletal muscle of pregnant dams. 
The current study demonstrates that consumption of a low protein diet throughout 
pregnancy altered multiple physiological outcomes in rat dams. Gestational weight gain was 
decreased in LP dams (after accounting for cumulative offspring birth weight), as were the birth 
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weights of the LP offspring. It has been reported that exposure of the pregnant rat to a low 
protein diet (8% protein content) causes a decrease in maternal body weight without a 
significant difference in food intake (187), which is consistent with findings from the current 
study. Fasting blood glucose levels of the LP rat dams (3.53 mmol/dL) trended to be lower 
(p=0.06) than Control (6.28 mmol/dL, data not shown), which is in agreement with the findings 
of Wapnir et al. showing that a LP diet can cause a decrease of fasted blood glucose in rats 
(188). Furthermore, muscle fiber perimeter was overall significantly different in LP dams when 
compared to controls. Previous studies have demonstrated that decreased fiber size is linked to 
myopathy (5), and our findings suggest that gestationally protein restricted dams adept to the 
growing protein needs of pregnancy through the breakdown of maternal muscle. 
We observed that a gestational LP diet was associated with significant decreases in 
maternal plasma Thr concentrations, consistent with a previous study showing that protein 
limitation decreases circulating Thr in pregnant rats (189). There were also changes in Lys, Ala 
and Ser concentrations in the LP group consistent with other studies reporting increased 
mobilization of maternal protein stores during dietary restriction (190). Increased plasma 
concentration of the essential amino acid Lys cannot be explained by de novo synthesis and 
can only result from increased protein breakdown or reduced hepatic catabolism. The 
breakdown of maternal protein stores by a gestational LP diet is further confirmed by the 
observed increase in Ala, which has a central role in gluconeogenesis and serves to remove 
nitrogen and recycle glucose carbon as part of the “alanine cycle” associated with branched-
chain amino acid oxidation in skeletal muscle (191). Increased Ala and Lys have also been 
previously observed in a pregnant pig model of protein restriction (192).  
At the end of gestation, the LP diet induced activation of the AAR and autophagy 
pathways in maternal skeletal muscle. The mechanism of AAR pathway activation in response 
to amino acid deprivation has been well documented in in vitro studies (167, 193), but remains 
poorly characterized in animals. Decreased Thr has been previously shown to activate the AAR 
pathway in HepG2 cells (194). In another study, a Thr deficient diet was found to activate the 
AAR pathway in an animal model (195, 196). The present study demonstrates that plasma 
decreases in Thr and His are primary indicators of protein limitation in maternal plasma after 
gestation, consistent with in vitro data for the activation of the AAR pathway (194). Our results 
show that a robust activation of the AAR pathway occurred only in skeletal muscle following a 
gestational LP diet, which was illustrated by the increased mRNA expression of the AAR 
responsive genes and ATF4 and p-eIF2alpha protein expression. Previous research has shown 
that increased ATF4 promoted skeletal myofiber atrophy during fasting (176). Moreover, 
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Naismith found that protein redistribution occurs during the pregnancy period (197), and it also 
has been shown that muscle has the greatest role during this period of active protein 
metabolism (197-199). While amino acid availability is associated with the regulation of 
autophagy in yeast and mammalian cells (200), in vivo data are scarce. In the current study, we 
showed that the LP diet induced activation of the autophagy pathway in the skeletal muscle of 
rat dams. Macroautophagy is highly associated with cellular metabolism, and autophagy in 
skeletal muscle has both beneficial and detrimental roles, depending on the stage of protein 
metabolism (201). It has been reported that starvation can induce autophagy in the muscle of 
mice (202). Furthermore, It has been shown that eIF2alpha/ATF4 play an important role in 
activating stress-induced autophagy gene expressions in vitro (203), and data from our study 
demonstrate that autophagy is also activated in the skeletal muscle of pregnant rats consuming 
a protein deficient diet.  
In support of the ATF4-induced gene expression in muscle, binding of the ATF4 
transcription factor was consistently increased at promoter regions of both AAR and autophagy 
pathway-related genes in response to the LP diet. We observed the binding of ATF4 at the Asns, 
Atf3 and Chop promoter regions, which was associated with induction of mRNA expression 
similar to the ATF4-mediated activation of the AAR pathway in vitro in hepatoma cells (167). 
Increased ATF4 binding also occurred within LC3a, LC3b, Atg4b and Bnip3 along with 
increased mRNA expression of these autophagy pathway related genes. In addition, ATF4 can 
regulate HIF1-targeted carbonic anhydrase 9 expression and Bnip3 is regulated by HIF1(204, 
205), which potentially suggests that ATF4 regulate Bnip3 with the help of HIF1. Further, we 
observed increased LC3B protein expression, which has been used as a biomarker for 
activation of autophagy in muscle (206). These data demonstrate that in addition to the role of 
ATF4 in the activation of the AAR pathway in response to protein restriction, this transcription 
factor also activates autophagy pathway-related genes in the muscle of protein-deficient 
pregnant dams. Furthermore, while gestational protein restriction has previously been shown to 
affect the skeletal muscle of offspring (207, 208), we further demonstrate that both AAR and 
autophagy pathways remain activated in male offspring long after gestational LP diet exposure, 
suggesting that activation of autophagy through ATF4-dependent AAR pathway in the mother 
may act as the molecular memory of the forthcoming expected environment to the offspring. A 
LP diet during pregnancy could be memorized in offspring in different ways. From physiological 
point of view, during pregnancy, fetuses obtain amino acid resource through umbilical cord from 
placenta. Therefore, altered amino acid profile in mother influences amino acid profile in fetuses 
directly. It has been shown that altered amino acid profile in fetus on pregnancy day 19 by 
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maternal LP diet (189). From molecular point of view, altered amino acid supply triggers 
subsequential signaling pathways in the embryonic development. A LP diet during pregnancy 
can program blastocyst development which may potentially due to altered maternal serum 
amino acids triggers mTOR signaling pathway in mouse (209). Moreover, epigenetics may be 
the key to explain the “memory”. Maternal programming model has been well established in 
gestational LP diet to investigate epigenetic regulation including histone modification and DNA 
methylation. The effect of epigenetics is tissue- and gender- dependent. Histone acetylation of 
Glut4 was induced by gestational LP diet in skeletal muscle of female offspring (210) and 
gestational low protein diet decreased histone H3 acetylation and methylation of p21 in 
mammary gland of offspring (87). Also, increased hepatic DNA methylation of Igf2 could be 
caused by a LP diet during pregnancy (211). Considering the evidence listed above, maternal 
LP diet is memorized in offspring through different mechanisms.  
Sex dimorphism of fetal programming has been studied intensively over the years. It 
potentially originates from placenta through sex-specific epigenetic regulations (212). Therefore, 
male and female respond differently to maternal protein restriction depends on metabolic 
pathway- and tissue- type. A LP diet during gestation can induce Glut4 expression in skeletal 
muscle of female offspring (210) and no effect in male offspring. However, the AAR pathway 
and autophagy related genes are only up-regulated in skeletal muscle of male offspring. It could 
involve hormonal regulation. The development of male skeletal muscle is related to male 
hormones (213). And it has been shown that a protein restriction diet during pregnancy and 
lactation impairs male testosterone level (214). The may explain differentiated transcriptional 
regulation of AAR pathway and autophagy in the skeletal muscle of male and female offspring. 
This study demonstrates that maternal protein restriction results in decreased Thr and 
His in plasma together with the activation of the ATF4-dependent AAR pathway, which may 
initiate autophagy in skeletal muscle of rat dams. We showed that the transcriptional activation 
of target genes was associated with binding of the ATF4 transcription factor at the promoter of 
these genes in the AAR and autophagy pathways. Furthermore, follow-up analysis in offspring 
of gestational protein restriction confirmed that both pathways remained activated in the skeletal 
muscle of offspring long after birth. Imbalanced and inadequate protein intake in women during 
pregnancy is an epidemic problem in developing countries(215, 216). Recently, a new cohort in 
Canada shows that the requirement for protein intake is actually higher than current 
recommendations in healthy pregnancy women during early- and late-gestation (217). However, 
few epidemiological studies focus on maternal response of protein restriction on mother. Not 
only offspring, but also mother has detrimental effects in response to protein restriction and our 
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study will shed light on maternal healthcare for both women and babies. Classifying these 
protein-sensing mechanisms in the mother may help to diagnose potential muscle-associated 
diseases in response to low protein intake during pregnancy, as well as to further investigate the 
precise role of maternal signaling in the growth restriction observed in offspring in response to 
maternal protein deficiency. 
3.6 Tables and Figures 
 
Table 3.1: Composition of diets 
	  Control (C) Low Protein (LP) 
Ingredients (g/kg) 20 kcal% protein 8 kcal% protein 
Casein 200 80 
L-Cystine 3 1.2 
Corn starch 397 519 
Maltodextrin 10 132 132 
Sucrose 100 100 
Cellulose, BW200 50 50 
Soybean oil 70 70 
Mineral Mix S10026 35 35 
Vitamin mix V10001 10 10 
Choline Bitartrate 2.5 2.5 
TBHQ 0.014 0.014 
Total 1000 1000 
Modified AIN-93 G diet    
Vitamin mix V10001 and Mineral mix S10026 are from Dyets, Inc, Bethlehem, PA. 
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Table 3.2: List of primers 
Gene (Ensemble 
No.Transcript ID)  Molecule type     Location                  Sequence 
ASNS  
(ENSRNOT00000010079) 
Genomic DNA 
Forward -83F GCG TCC TTC GTC AGC ATT G 
Reverse -7R CGT GCG GGA AGT TTC ATC 
mRNA 
Forward +11091F TGG ACT CCA GCT TGG TTG 
Reverse +11157R AGA GCA TAG GGC ACT TGG 
ATF3  
(ENSRNOT00000005085) 
Genomic DNA 
Forward -125F GGC CAG TTC TCC CTG GAA GCT AT 
Reverse -56R CCC GCT TAA CTC CTG GTT ACC AAT 
mRNA 
Forward +688F AGA AGG AAC ATT GCA GAG CTA AGC 
Reverse +767R TGG GGT GGA AAA GGA GGA TTC 
CHOP 
(ENSRNOG00000006789) 
Genomic DNA 
Forward -99F CGT GCC GCT TTC TGA TTG 
Reverse -36R ATG CTA TTC GGT CCC TCC 
mRNA 
Forward +636F CTC TGA TCG ACC GCA TGG TCA G 
Reverse +731R TGG CGT GAT GGT GCT GGG 
L7a 
(ENSRNOT00000006754) mRNA 
Forward +64F GAG GCC AAA AAG GTG GTC AAT CC 
Reverse +127R CCT GCC CAA TGC CGA AGT TCT 
Actb 
(ENSRNOT00000042459) mRNA 
Forward +451F GAG ACC TTC AAC ACC CCA GC 
Reverse +526R CAG TGG TAC GAC CAG AGG CA 
Tbp 
(ENSRNOT00000014605)  mRNA 
Forward +600F CAG GCA CCA CCC CCT TGT ATC CTT C 
Reverse +679R AGA GCT CTC AGA GGC TGG TGT GGC A 
Map1lc3a 
(ENSRNOT00000035060) 
Genomic DNA 
Forward -125F CTG GCT TCA CAG TCC TGA GG 
Reverse -56R TAA GGG GGC GGA GCT ACA 
mRNA 
Forward +688F AGA AGG AAC ATT GCA GAG CTA AGC 
Reverse +767R TGG GGT GGA AAA GGA GGA TTC 
Map1lc3b 
(ENSRNOT00000051352) 
Genomic DNA 
Forward -244F AGC CAG GAG CAG AAG ATG AA 
Reverse -156R TGA GTC GGC TTC CCA AAA 
mRNA Forward +626F GTG TTG TGG AAG AAT GCC 
 Reverse +726R TCA CCC TTG TAT CGC TCT 
Bnip3 
(ENSRNOT00000023477) 
Genomic DNA 
 Forward -488F ATG CTT CTG TCA CTG GCG 
reverse -394R CTG GGG TTG GGT ATG GAT 
mRNA 
Forward  +652F AAG GCG TCT GAC AAC TTC CA 
Reverse +739R TCA CAG CTC AGC GTG AAT 
Atg4b 
(ENSRNOT00000025529) 
Genomic DNA 
Forward -175F TGG TGA GAC CTG AGT TGC TG 
Reverse -89R CTG CTC ATC GGG GAA TGA 
mRNA 
Forward +24F GAG TGT TCT CAC TTT CCG 
Reverse +113R ATC ACC ACA GTG TTG TCC 
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Table 3.3: List of antibodies 
 
Cat. Number Lot No. Company name 
Name Modification 
Actin(I-19)-R  sc-1616-R C0907 Santa Cruz Biotechnology, Inc, Santa Cruz, CA 
CREB-2(C-20)  sc-200 H2008 Santa Cruz Biotechnology, Inc, Santa Cruz, CA 
Normal rabbit IgG  sc-2027 F1608 Santa Cruz Biotechnology, Inc, Santa Cruz, CA  
p-eIF2alpha p-S51 9721L Lot 7 Cell Signaling Technology, Inc, Danvers, MA 
Total eIF2alpha  9722 Lot 11 Cell Signaling Technology, Inc, Danvers, MA 
LC3B  Ab48394 Lot 4 Abcam, Cambridge, MA 
 
Table 3.4: Selected plasma amino acids in rat dams after gestation 
Amino Acids (μmol/L) Control (20 kcal% protein) LP (8 kcal% protein) 
Lys 1440 ± 49 1830 ± 55*1 
Thr 973 ± 60 604 ± 85*1 
His 961 ± 56 598 ± 61*1 
Ala 692 ± 22 1020 ± 61*1 
Ser 741 ± 32 1140 ± 135*1 
1. Values presented as Mean ± SEM, n >5. *Different from Control within each experiment, p<0.05  
 
Table 3.5: Selected plasma amino acids in rat dams at sacrifice that were not changed 
Amino Acids (μmol/L) Control (20 kcal% protein) LP (8 kcal% protein) 
Leu 202 ± 8 199 ± 38 
Ile 138 ±16 144 ± 21 
Val 269 ± 20 260 ± 30 
Met 81 ± 3 73 ± 5 
Glu 133 ± 9 134 ± 14 
Asp 73 ± 7 51 ± 9 
Pro 343 ± 16 317 ± 34 
Tyr 99 ± 8 99 ± 15 
Arg 617± 49 559 ± 40 
Gly 489 ± 48 622 ± 18 
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Figure 3.1: Body weight (A) and food intake (B), gestational weight gain (C), offspring birth 
weight (D) and gestational net weight gain (E) in rat dams consuming a Control (Control) or low 
protein (LP) diet throughout gestation from study 1. Values are means ± SEM, n=6. Where not 
visible, the error bars are too small to be seen. *p<0.05 and **p<0.01 when compared to control. 
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Figure 3.1 
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Figure 3.2: H&E staining (A), quantification (B and D) and distribution analysis (C) of skeletal 
muscle fibers in rat dams consuming a Control (Control) or low protein (LP) diet throughout 
gestation from study 1. H&E staining was used to investigate the structural changes in the 
skeletal muscle of rat dams following a gestational LP diet. Two representative images were 
chosen to show the structural differences of skeletal muscle between Control and LP groups at 
20X magnification. The open arrow points to the clustered basophilic fibers and the filled arrow 
points to the varied size of muscle fibers and splitting muscle fibers. For quantification of the 
muscle fiber percentage by different diameter ranges, each bar consists of the fiber number 
percentage distribution in four different ranges of muscle fiber diameters including 0-45 (white), 
46-64 (light grey), 66-91 (dark grey) and 92-140 um (black). The x-axis represents the treatment 
group, while the y-axis shows the percentage of fiber numbers in each diameter range. Values 
are means ± SEM. n=6. *p<0.05 when compared to control. For the distribution curve of fiber 
number percentages, open triangles represent the Control group, while filled squares stand for 
the LP group. X-axis shows a series of fiber diameters, and the y-axis shows the fiber number 
percentage. n=6. Values are means ± SEM. For analysis of average muscle fiber sizes, the red 
dots represent the control group, while as black dots represent the LP group. 
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  Figure 3.2 
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Figure 3.3: mRNA expression of Asns, Atf3 and Chop in muscle (A), liver (B), adipose (B), and 
blood (B) in rat dams consuming a Control (Control) or low protein (LP) diet throughout 
gestation from study 1. To detect the activation of the AAR pathway, mRNA expression was 
analyzed by two-step real-time RT-PCR in skeletal muscle. All data were normalized to Actb 
(muscle) or L7a (liver, adipose and blood) housekeeping gene, and data from the LP group 
were further normalized to Control. Values are means ± SEM, n=6. *p<0.05 and **p<0.01 when 
compared to control.  
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Figure 3.3 
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Figure 3.4: Protein expression of phosphorylated eIF2alpha (A and C) and ATF4 (B and C) and 
binding of ATF4 on the promoters of Asns, Atf3 and Chop (D) in rat dams consuming a Control 
(Control) or low protein (LP) diet throughout gestation from study 1. Total eIF2alpha was used to 
normalize the phosphorylation of eIF2apha, and Actin was used to normalize the protein 
expression of ATF4. The immunoblots shown are all available samples and the quantification 
represents mean ± SEM. For chromatin immunoprecipitation analysis, the x-axis represents the 
antibodies analyzed, while the y-axis represents the protein binding levels, ratio to input. n=6. 
*p<0.05 and **p<0.01 when compared to control.  
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  Figure 3.4 
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Figure 3.5: A schematic diagram of cellular autophagy (A), autophagy gene expression (B) and 
LC3B protein expression (C) in skeletal muscle of rat dams consuming a Control (Control) or 
low protein (LP) diet throughout gestation from study 1. To detect the activation of the 
autophagy pathway, mRNA expression was analyzed by two-step real-time RT-PCR in skeletal 
muscle. All data were normalized to Actb housekeeping gene, and data from the LP group were 
further normalized to Control. Values are means ± SEM, n=6. *p<0.05 and **p<0.01 when 
compared to control. Actin was used to normalize the protein expression of LC3B. The 
immunoblots shown are all available samples and the quantification represents mean ± SEM. 
n=6. *p<0.05 and **p<0.01 when compared to control. 
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 Figure 3.5 
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Figure 3.6: Binding of ATF4 on autophagy genes (A and B) in rat dams consuming a Control 
(Control) or low protein (LP) diet throughout gestation from study 1. Transcription factor ATF4 
binding sites at the promoters of Map1lc3a, Map1lc3b, Atg4b and Bnip3 were predicted by 
Genomatix software. For chromatin immunoprecipitation analysis, the x-axis represents the 
autophagy related genes examined, while the y-axis represents the protein binding levels, ratio 
to input. n=6. *p<0.05 and **p<0.01 when compared to control. 
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Figure 3.6
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Figure 3.7: mRNA expression of AAR Pathway (A) and autophagy pathway (B) related genes in 
skeletal muscle of offspring whose dams consumed a Control (Control) or low protein (LP) diet 
throughout gestation from study 2. To detect the activation of the AAR pathway and autophagy 
in offspring, mRNA expression was analyzed by two-step real-time RT-PCR in skeletal muscle. 
All data were normalized to L7a housekeeping gene, and data from maternal LP group were 
further normalized to Control. Values are means ± SEM, n=6. *p<0.05 and **p<0.01 when 
compared to control. 
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Figure 3.7
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Figure 3.8: A diagram of proposed maternal programming mechanism by a gestational low 
protein diet in rat dams. Our results highlight that a gestational low protein diet activates the 
AAR pathway and potentially initiates autophagy in the skeletal muscle of rat dams. The signal 
potentially transduces to placenta and further to skeletal muscle of male offspring and which 
may potentially link to stunted growth in offspring.  
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Figure 3.8
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CHAPTER 4  
HEPATIC AUTOPHAGY INDUCED BY GESTATIONAL AND LACTATIONAL LOW PROTEIN 
DIET MAY CAUSE LIPID ACCUMULATION IN THE RAT DAM 
4.1 Abstract 
Impaired ApoB and MTP are associated with non-alcoholic fatty liver diseases in mice. A low 
protein (LP) diet during gestation and lactation causes hepatic lipid accumulation in rodents but 
the molecular mechanisms are poorly understood. Autophagy, essential for cellular lipid 
homeostasis, is activated in liver cells by amino acid deprivation. Also, transcriptional activation 
of LC3b, a primary autophagy marker, is related to histone acetylation, which can be regulated 
by HDAC3, a histone deacetylase. The present study examined the mechanism of a LP diet on 
hepatic lipid accumulation during gestation and lactation. Timed-pregnant Sprague-Dawley rats 
were fed a control (Control, 20 kcal% protein) or a low protein (LP, 8 kcal% protein) diet during 
gestation and lactation. Histological analysis, qRT-PCR, western blot, immunofluorescence, 
transfection of mammalian cells were applied to investigate the mechanism of LP diet-induced 
hepatic lipid accumulation. LP dams had increased hepatic TG accumulation and significantly 
higher AST/ALT, which was accompanied with decreased circulating VLDL/LDL. Autophagy 
was induced in LP dams, along with increased histone acetylation, decreased Hdac3 mRNA 
expression. LP diet induced co-localization of LC3 binding motif (LIR) interacting proteins, ApoB 
or MTP with LC3B, suggesting increased selective autophagic degradation. The relationship 
between HDAC3, LC3B and lipid accumulation were determined in HepG2 cells. 
Overexpression and knockdown of HDAC3 showed that repression of HDAC3 induced LC3B 
expression, and HDAC3 is necessary to prevent lipid accumulation in response to amino acid 
deprivation in HepG2 cells. Moreover, overexpression and knockdown of LC3 proved LC3B 
increased lipid accumulation. Conclusion: We showed that HDAC3 regulated LC3B-induced 
lipid accumulation potentially through autophagic degradation of ApoB and MTP in response to 
amino acid deprivation in liver.  
4.2 Introduction 
Maternal metabolism is altered drastically during pregnancy and lactation, and maternal nutrition 
is essential to support these changes (14, 15). During pregnancy, maternal metabolism adapts 
to the needs of the developing embryo and in preparation for milk production by increasing 
glucose uptake and energy metabolism (24). Also, the adaptation to lactation is associated with 
increased maternal food intake and enlarged liver size (218).  Liver, an energy metabolism-
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related organ, has been shown to go through dynamic physiological changes during gestation 
and lactation. Specifically, hepatic fatty acid infiltration and altered lipid metabolism have been 
shown during these periods in animals (219, 220). Taking into account the critical role of liver in 
maternal metabolism, it is important to understand the molecular mechanisms behind maternal 
hepatic lipid accumulation in response to protein restriction during gestation and lactation. The 
low-protein (LP) rodent model, one of the best-characterized developmental programming 
models, suggests that a LP diet is associated with reduced body weight gain in pregnant rats 
(45) and a gestational and lactational LP diet favored lipid accumulation by alteration of lipid 
metabolism including increased hepatic lipogenesis in rats (4, 46). While these studies suggest 
that a LP diet during gestation and lactation affects maternal energy metabolism, the 
mechanisms behind the maternal metabolic alterations during gestation and lactation have not 
been well elucidated.  
Amino acid deprivation activated autophagy-related pathway in MEF cells (6).  
Autophagy, primarily known as macroautophagy in cellular metabolism, involves cell 
degradation of unnecessary or dysfunctional cellular components (118). Microtubule-associated 
protein 1 A/B light chain 3 (LC3) is a primary marker of autophagosome (123). The initiation of 
autophagy is highly associated with lipid droplet formation surrounding LC3 in mouse 
hepatocytes (125, 126). ApoB and MTP, involved in VLDL synthesis, are potentially regulated 
by autophagic degradation (221). As previously discussed, LP diet/amino acid deprivation 
induces lipid accumulation and autophagy in experimental models, but few studies investigate 
the role that autophagy potentially plays in LP diet-induced lipid accumulation during gestation 
and lactation. Epigenetic modification potentially contributes to developmental plasticity in 
response to environment changes in animals and human (129, 130). Histone lysine acetylation 
is a dynamic process that could be controlled by antagonistic actions of histone deacetylases 
(HDACs) (222).  In particular, HDAC3 represses transcription by serving a co-repressor when 
directed to promoter regions (222). In liver, studies have shown that deletion of HDAC3 causes 
lipid accumulation (12, 13).  Also, HDAC3 is associated with autophagic regulation, along with 
increased expression of LC3B (223-225). Because HDAC3 could modulate hepatic lipid 
metabolism and autophagy, it is important to understand the relationship between lipid 
accumulation and autophagy and the potential regulatory effects of HDAC3 in the liver in our 
model. 
The aim of the present study was to investigate the potential role of LC3B in hepatic lipid 
accumulation and HDAC3 regulation by utilizing this LP rat model. 
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4.3 Materials and Methods 
Animals and Diets 
Timed-pregnant Sprague-Dawley rats (n=7) were obtained from Charles River Laboratories 
(Charles River Laboratories, Wilmington, MA) and randomly assigned into one of the two 
isocaloric diets (Research diet Inc., New Brunswick, NJ; Table 1): control diet (Control, 20 kcal% 
protein) or low protein diet (LP, 8 kcal% protein) from day 2 of gestation to the end of lactation. 
Diet composition is in Table 4.1. After delivery, ten pups were randomly assigned to each 
lactating dams until at weaning. Animals were housed individually in standard polycarbonate 
cages in humidity- and temperature- controlled environment on a 12-h light-dark cycle. Body 
weight and food intake were recorded every other day.  
Rats were fasted for 8 h before sacrifice and euthanized by carbon dioxide for 20 s 
before decapitated to collect blood for serum isolation. Liver samples were snap frozen in liquid 
nitrogen and stored at -80 °C for future measurements. All experiments were conducted in 
accordance with the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals 1996 and were approved by University of Illinois at Urbana-Champaign Institutional 
Committee on health care.  
 
Histological Analysis  
Seven frozen liver samples in each treatment were embedded in Tissue-Tek OCT compound 
(VWR, Radnor, PA) and cross-sectionally cut to 7 µm thickness using a Leica CM3050 S 
cryostat (Leica Microsystems Inc., IL) at -20 °C as previously reported (226). All sections were 
fixed in 70% ethanol and stained with hematoxylin and eosin (H&E) and Oil Red O solution 
(Newcomer Supply). Slides were scanned using Nanozoomer Digital Pathology System with 
magnification of 20X (Hamamatsu Photonics K.K., Japan), and image analysis was performed 
by ImageJ software. Three independent regions from each section were selected for 
quantification by a pathologist blinded to the treatments.  
 
Biochemical Analysis of Liver Tissue 
To determine hepatic TG levels, frozen liver samples were ground in liquid nitrogen and 
homogenized in 0.3 mL saline (0.9% w/v NaCl). Homogenized samples were diluted 5 times 
with saline. Twenty microliter of the diluted samples were incubated with 20 µL 1% 
deoxycholate in 37 °C for 5 min and 10 µL of the sample were analyzed using the Thermo 
Infinity Triglycerides Liquid Stable Reagent (Thermo Fisher Scientific). A standard reference kit 
(Verichem Laboratories) was used to determine the TG content as previously reported (226).  
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Glycogen content was measured following manufacturer’s instruction (MAK016, Sigma-
Aldrich, St. Louis, MO). The samples and glycogen standard were measured with the 
colorimetrical OD value at 570 nm. Results were considered to be acceptable with a CV less 
than 15%, as recommended by the manufacturer. The results fell within recommended 
detection limits. 
 
Serum Measurements 
Following an eight h fast, serum samples were obtained from trunk blood collected immediately 
after delivery by centrifugation at 800 g for 20 min at 4 °C. Serum samples were kept in -70 °C 
until analysis. 
The VLDL/LDL (MAK045, Sigma-Aldrich, St. Louis, MO), AST (MAK055, Sigma-Aldrich, 
St. Louis, MO) and ALT (MAK052, Sigma-Aldrich, St. Louis, MO) were measured according to 
manufacturer’s instruction to determine hepatic function in rats. Results were considered to be 
acceptable with a CV less than 15%, as recommended by the manufacturer. The results fell 
within recommended detection limits. 
 
RNA Isolation and RT-PCR Analysis 
Total RNA was isolated with Tri-reagent (Sigma-Aldrich, St. Louis, MO) according to the 
manufacturer’s instruction, and quantified by Bio-Rad spectrophotometer (Bio-Rad laboratories 
Inc, Irvine, CA) at 260 nm. Two microgram of RNA were synthesized using High Capacity cDNA 
Reverse transcription Kit (Applied Biosysterms, Foster City, CA) and a DNA 2720 Thermal 
Cycler (Applied Biosystems, Foster City, CA). After synthesis, 25 ng of cDNA was analyzed 
using quantitative real-time PCR and gene expression was detected by 2x Perfecta SYBR 
Green master mix (Quanta BioSciences, www.vwr.com) with a 7300 real-time PCR system 
(Applied Biosystems, Foster City, CA) as previously reported (227). Standard curves with slope 
of -3.30±0.20 and R2≥0.99 were accepted. Tbp and Gapdh were used as internal controls to 
normalize the raw data. Primers information is in Table 4.2. 
 
Protein Isolation and Western Blotting 
Frozen liver (200 mg) was ground in liquid nitrogen and suspended in 500 µL of protein lysis 
buffer with 1x proteinase inhibitor (Roche applied sciences, Indianapolis, IN) and phosphatase 
inhibitor cocktail 1 and 2 (Sigma-Aldrich, St. Lois, MO) as previously described (227). To 
investigate HDAC3 (Abcam, Cambridge, MA) and LC3B (Abcam, Cambridge, MA) protein 
expression, the PVDF membranes were blocked with 10% (w/v) nonfat dry milk, incubated with 
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the indicated antibodies (See figure legends), and then incubated with appropriate antibodies 
conjugated with horseradish peroxidase. Actin (SC-1616-R, Santa Cruz, CA) was used as a 
loading control. Antibodies information is in Table 4.3. 
 
Immunofluorescence Staining 
Frozen liver samples were embedded in Tissue-Tek OCT compound (VWR, Radnor, PA) and 
cut to a thickness of 5 µm in a cryostat at -20 C. The sections were fixed in 70% ethanol, 
permeablized with 0.1% Triton X-100, blocked with Image-iT FX signal enhancer (Invitrogen, 
Carlsbad, CA) for 30 min. To investigate the co-localization of LC3B (Abcam, Cambridge, MA) 
with ApoB (Santa Cruz, CA) and MTP (Santa Cruz, CA), antibodies were incubated for 2 h at 37 
C, and followed by incubation with appropriate secondary antibodies (Alexa Fluor 647, 488 
1:200 dilution, Invitrogen, Carlsbad, CA) and BODIPY493/503 (1:1000, Invitrogen, Carlsbad, 
CA) for 45 min in a dark chamber. The samples were then counterstained with Hoechst 33342 
(Invitrogen, Carlsbad, CA) for 15 min and washed with PBS. Coverslip was mounted using 
Prolong Gold antifade reagent (Invitrogen, Carlsbad, CA). Pictures were taken by LSM700 
confocal microscope (Carl Zeiss Microscopy, LLC, United States). Antibodies are listed in Table 
4.3. 
 
Chromatin Immunoprecipitation (ChIP)  
To determine specific histone modifications and HDAC3 binding on the promoter of LC3b, ChIP 
analysis was performed according to a modified protocol (228). Briefly, 200 mg frozen liver was 
ground in liquid nitrogen and suspended in PBS. Protein-DNA cross-linking was performed, and 
sheered on ice by a Sonic Dismembrator (model F100, Fisher Scientific, Pittsburgh, PA) for 40 s 
at power setting 5 with 2 min cooling interval between each burst, four bursts for rat samples 
and 5 burst for cell samples. Sheared-chromatin was incubated with specific antibodies (see 
figure legends), and precipitated with pre-blocked protein G-agarose beads (Millipore, Billerica, 
MA). A normal rabbit IgG was used as a negative control. Supernatant from incubated IgG was 
saved as the input DNA for each sample. Then protein-DNA complexes were eluted and 
reverse cross-linked. Chromatin DNA was purified using QiaPrep miniprep kit (Qiagen, 
Valencia, CA). The results were expressed as ratio to input DNA. Antibodies are listed in Table 
4.3. 
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Cell Culture and Transfection Assay 
H4IIEC3 and HepG2 cells were obtained from ATCC (Manassas, VA). The cells were 
maintained in minimum essential medium (MEM) as previously reported (227). All experiments 
were performed using cells with 2-6 passages. To investigate the effects of amino acid 
deprivation, HepG2 cells were treated in triplicate with amino acid-deprived media (-AA) for 4 h.  
Samples were collected for mRNA, protein and Oil red O analysis. For knockdown of LC3B and 
HDAC3, cells were transfected with HDAC3 and LC3B siRNA (HDAC3si and LC3Bsi) or control 
anti-scramble siRNA (NSsi) (Integrated DNA Technologies, Inc., Coraville, IA). For 
overexpression of LC3 and HDAC3, HepG2 cells were cultured as described above and 
transfected with either the control plasmid (Vector) or LC3-containing GFP (LC3) or HDAC3 
plasmid (pcmv-HDAC3, HDAC3, OriGene, Rockville, MD). The empty plpcx-GFP vector was 
used as a transfection control. After transfection with Superfect Transfection Reagent (Qiagen, 
Valencia, CA), cells were replenished with fresh MEM for 48 h. Amino acid deprivation was 
followed standard procedure (79). Transfection with siRNA, plpcx-GFP (Vector), GFP-LC3 
(LC3) and pcmv-HDAC3 (HDAC3) plasmids followed the published procedures in our lab (227). 
Cells were seeded in a six-well plate at 0.2 million cells/well on top of 22- x 22- mm 
coverslips for Oil red O staining, at 0.4 million cells/well for mRNA and protein isolations (n=3). 
Amino acid deprivation was performed at 4 h. The 4 h was chosen based on previous time-
course studies (data not shown) showing that significantly decreased Hdac3, induced LC3B 
expression and increased lipid accumulation by 4 h in -AA when compared to MEM. 
 
Statistical Analysis 
Results are reported as the mean ± SEM for in vivo experiments (n=7), and for in vitro 
experiments (n=3). To determine lipid accumulation in liver cells, results were presented from 9 
randomly selected images per section, three individual sections per sample previously stained 
and scanned for Oil red O experiment. ImageJ (Rasband, W.S., ImageJ, U. S. National 
Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2014) was applied 
to evaluate the intensity of stained red per cell. Food intake and body weight were analyzed by 
repeated-measures One-way ANOVA (SAS Institute Inc., Cary, NC). For other results, student’s 
t-tests were used to compare liver weight, liver TG, liver glycogen, serum VLDL/LDL, AST and 
ALT, mRNA expression, protein expression, ChIP and percentage of intensity for Oil Red O, 
immunofluorescence staining and overexpression experiment between Control and LP groups. 
Differences were considered significant at *p<0.05. 
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4.4 Results 
A Low Protein Diet Induced Hepatic Lipid Accumulation and Decreased Liver Function in Rat 
Dams 
Maternal food intake, body weight, liver weight and histological analysis were assessed as 
markers of the physiological impacts of a LP diet during gestation and lactation. Gestational 
food intake of LP dams appeared to be less than in Control dams, but this was not significantly 
different (data not shown). LP dams ate less from gestational days 9 to 21, and weighed less 
from lactational days 17 to 21 when compared to Control dams (p<0.05, Figure 4.1A). At 
weaning, liver weights of LP dams were 20% heavier than Control dams (p<0.05, ratio of liver 
weight to body weight, Figure 4.1B).  
Biochemical analyses, including hepatic triacylglycerides (TG) and glycogen content, 
serum VLDL/LDL, HDL, AST and ALT were also performed in rat dams. LP dams had increased 
hepatic TG and decreased circulating VLDL/LDL than Control dams (p<0.05, Figure 4.1E and 
4.1F). HDL was not significantly different between Control and LP dams (Table 4.4). In order to 
investigate the cause for the enlarged liver in LP dams, H&E and Oil Red O staining were 
performed. LP dams had more hepatic vacuoles than Control dams (Figure 4.1C), and the LP 
diet increased hepatic lipid accumulation by 7-fold (p<0.05, Figure 4.1C and 4.1D). Hepatic 
glycogen content was also assessed to further investigate the cause of the observed enlarged 
liver in LP dams. LP dams had decreased hepatic glycogen than Control dams, suggesting that 
TG was the main contributor to the increase in liver size in LP dams. Serum AST and ALT were 
analyzed to evaluate liver function in rat dams. LP dams had increased ratio of circulating AST 
to ALT (ratio>2, p<0.05, Table 4.4, indicating potential risks of fatty liver disease (229).  
 
A Low Protein Diet Induced Hepatic Autophagy 
It has been shown that initiation of autophagy is associated with lipid droplet formation 
surrounding LC3 (123) in mouse hepatocyte (125, 126), and an in vitro study showed that amino 
acid deprivation induced autophagy (6). To investigate whether autophagy was activated in our 
LP model, mRNA expression of autophagy-related genes was analyzed. LP dams had 
increased mRNA expression of autophagy-related genes including Bnip3, LC3a and Atg2a 
(p<0.05), while Atg4b was not significantly different between Control and LP dams (Figure 4.2). 
To further investigate the molecular markers of autophagy, mRNA and protein expression of 
LC3B were examined. LP dams had increased mRNA and protein expression of LC3B (p<0.05, 
Figure 4.3A). Moreover, Immunofluorescence staining showed that LP diet increased hepatic 
LC3B abundance and lipid accumulation as shown by BODIPY-stained fatty acids (p<0.05, 
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Figure 4.3B and 4.3C). Based on the abundance of BODIPY staining from 20 randomly 
selected LP images, from low to high, LP-I, LP-II and LP-III were chosen as representative 
images (comprised of 30%, 30% and 40% of total images, respectively, Figure 4.3B). LP-I and 
LP-II showed that LC3B was localized around lipids, while LP-III showed that overflow of lipid 
was not positively correlated with LC3B abundance. 
 
A Low Protein Diet Induced Hepatic LC3b Histone Acetylation and Involved HDAC3 Repression 
To further investigate the molecular mechanisms of increased LC3B expression in the livers of 
LP dams, histone modification on the promoter of LC3b was analyzed. LP diet increased 
acetylation of histone H3 (H3Ac) and di-methylation of histone H3 lysine 4 (H3K4Me2) on the 
promoter of LC3b (p<0.05, Figure 4.3D), which has been correlated with transcriptional 
activation (230) and agrees with the increased mRNA expression of LC3b in LP dams observed 
in the current study. The LP diet also decreased hepatic Hdac3 mRNA expression in rats 
(p<0.05, Figure 4.3E), and in our in vitro study in H4IIEC3 cells, HDAC3 binding was decreased 
on the promoter of LC3b (p<0.05, Figure 4.3F). 
 
Knockdown of HDAC3 Induced Lipid Accumulation and LC3B Expression in HepG2 cells 
To determine whether a decrease of HDAC3 increased LC3B expression and lipid accumulation 
in response to amino acid deprivation, a human hepatoma cell line HepG2 was utilized. 
Knockdown of HDAC3 was validated by protein and mRNA expression of HDAC3 (p<0.05, 
Figure 4.4A and 4.4B). Amino acid deprivation increased both protein (p<0.05, Figure 4.4C) 
and mRNA expression (p<0.05, Figure 4.4D) of LC3B and also increased lipid accumulation in 
cells not expressing HDAC3 (p<0.05, Figure 4.4E and 4.4F). 
 
Overexpression of HDAC3 Alleviated Lipid Accumulation in Response to Amino Acid 
Deprivation in HepG2 Cells 
To further investigate the role of HDAC3 in increased LC3B expression and lipid accumulation, 
HDAC3 was overexpressed in HepG2 cells. Overexpression experiment was validated through 
increased protein and mRNA expression of HDAC3 (p<0.05, Figure 4.5A and 4B). Interestingly, 
amino acid deprivation had no effect on either the protein or mRNA expression of LC3B in cells 
overexpressing HDAC3 (Figure 4.5C and 4.5D). However, amino acid deprivation-induced lipid 
accumulation, was abolished in HDAC3-overexpressing HepG2 cells (p<0.05, Figure 4.5E and 
4.5F). 
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These experiments where HDAC3 was either knocked down or overexpressed 
demonstrated that repression of HDAC3 induced LC3B, and HDAC3 was necessary to prevent 
lipid accumulation in response to −AA in HepG2 cells. 
 
A Low Protein Diet Selectively Induced ApoB and MTP Autophagy in Rat Dams 
ApoB autophagy has been shown to explain the degradation of ApoB protein through autophagy 
(221). The LC3 binding motif (LIR), a functional peptide sequence W/Y/F-X1-X2-L/I/V, revealed 
the potential specificity of autophagic degradation (231). Because LP diet increased lipid 
accumulation, mRNA expression of lipid metabolism-related genes, including fatty acid 
synthesis, VLDL synthesis, transcriptional regulation and fatty acid beta-oxidation were 
analyzed. LP diet decreased mRNA expression of Acc1, Fasn, Srebp1 and PPARg, indicating 
decreased de novo lipogenesis (p<0.05, Figure 4.6A). Additionally, LP diet increased mRNA 
expression of Cpt1a and Acox1, suggesting increased fatty acid beta-oxidation (p<0.05, Figure 
4.6A). Interestingly, mRNA expression of Mttp and ApoB100 were decreased in LP dams, 
suggesting decreased VLDL synthesis (p<0.05, Figure 4.6A). Overall, the observed lipid 
accumulation in the livers of LP dams in the current study could potentially be attributed to 
impaired VLDL synthesis and lipid export, rather than de novo lipogenesis and fatty acid beta-
oxidation. 
To examine the specificity of ApoB and MTP autophagic degradation, LIR was found in 
ApoB and MTP protein sequences (Figure 4.7A), but not in ApoC-I (Figure 4.6B), another 
apolipoprotein associated with nascent VLDL synthesis, suggesting that autophagy potentially 
degraded ApoB and MTP specifically and blocked hepatic lipid export. To investigate the 
interaction between LC3B and ApoB, LC3B and MTP, the co-localization of LC3B and ApoB, 
LC3B and MTP were analyzed by immunofluorescence. LP diet appeared to increase LC3B 
abundance and decrease ApoB and MTP (Figure 4.7B and 4.7D) abundance, which was 
confirmed by quantifying the fluorescent signal (p<0.05, Figure 4.7C and 4.7E). According to 
the process of degradation, LP-a, LP-b and LP-c were selected as representative stages to 
show co-localization of LC3B with ApoB (Figure 4.7C) and LC3B with MTP (Figure 4.7D) in LP 
groups. LP-a showed potential initiation of co-localization, LP-b showed the peak co-localization 
and LP-c showed the late-stage degradation of ApoB and MTP. Overall, in the Control group, 
neither ApoB nor MTP co-localized with LC3B. However, LC3B strongly co-localized with ApoB 
(Figure 4.7B) and MTP (Figure 4.7D) in the LP group.  
 
 
	  67 
LC3B Induced Lipid Accumulation in Response to Amino Acid Deprivation in HepG2 Cells 
To determine whether LC3B increased lipid accumulation in response to amino acid deprivation, 
LC3B was silenced by siRNA in HepG2 cells. Protein and mRNA expression of LC3B were 
decreased in cells not expressing LC3B (p<0.05, Figure 4.8A). Knockdown of LC3B abolished 
lipid accumulation following amino acid deprivation (p<0.05, Figure 4.8B and 4.8C). To further 
investigate the mechanisms behind this observed outcome, LC3 was overexpressed in HepG2 
cells. Overexpression of LC3 was confirmed by increased protein and mRNA expression of 
LC3B (p<0.05, Figure 4.8D). Oil red O analysis showed that overexpression of LC3 increased 
lipid accumulation in both Control and amino acid-deprived cells (p<0.05, Figure 4.8E and 
4.8F). 
Overall, our results suggest that the repression of HDAC3 increased LC3B expression 
and caused lipid accumulation through ApoB and MTP autophagy. 
 
4.5 Discussion 
To our knowledge, our study is among the first to show a novel molecular mechanism where a 
gestational and lactational LP diet degrades ApoB and MTP proteins through autophagy, 
ultimately causing hepatic lipid accumulation in rats.  
First, a LP diet throughout gestation and lactation altered physiological outcomes in rats. 
LP diet significantly decreased maternal food intake and body weight during lactation. Also, LP 
diet significantly increased liver weight, which agreed with increased lipid accumulation and 
hepatic TG content. We also showed increased hepatic vacuolation, which agreed with 
published results from Velazquez-Villegas (4). Additionally, LP diet significantly increased ratio 
of AST to ALT (>2), which has been shown to be a marker of liver damage (229). Furthermore, 
LP diet significantly decreased circulating VLDL/LDL, together with decreased mRNA 
expression of ApoB and Mttp, indicating impaired VLDL synthesis in the liver. Our study is 
among the first to reveal that a maternal LP diet damaged liver function together with increased 
TG and lipid accumulation in rats. 
Second, LP diet induced hepatic ApoB and MTP autophagy and increased lipid 
accumulation in the liver of rat dams. It has been shown that autophagy is associated with lipid 
droplet formation in in vitro studies (125, 126). Our study is among the first to show that LP diet 
induced hepatic autophagy, coinciding with increased lipid accumulation in rats. It has been 
shown that the inhibition of autophagy increased TG storage in hepatocytes and mouse liver 
(126). However, in the current study, the knockdown of LC3B did not increase lipid 
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accumulation in either control or amino acid-deprived cells, suggesting that lipid accumulation 
observed in our study occurred through a different mechanism. It is possible that the initiation of 
autophagy requires lipid formation, and autophagy degrades lipids after prolonged amino acid 
deprivation. Moreover, it has been shown that leucine deprivation halted lipid mobilization from 
liver to peripheral tissues, but the mechanism was not well elucidated (232). Our study showed 
the possibility that LP diet impaired VLDL synthesis through autophagic degradation of VLDL 
synthesis-related proteins including ApoB and MTP. We showed that hepatic lipid accumulation 
coincided with increased LC3B expression, which co-localized with ApoB and MTP. 
Overexpression and knockdown of LC3B demonstrated that LC3B increased lipid accumulation 
in response to amino acid deprivation in HepG2 cells. 
Third, LP diet epigenetically regulated LC3b expression and lipid accumulation. It has 
been shown that the inhibition of HDAC3 was associated with autophagy in mice (223) and 
decreased HDAC3 altered lipid metabolism through the activation of PPARg2 (233). Our study 
is among the first to show that the induction of LC3b was epigenetically regulated and was also 
involved in lipid accumulation. LP diet induced H3Ac on the promoter of the LC3b gene, and 
decreased mRNA expression of Hdac3. Overexpression and knockdown of HDAC3 proved that 
repression of HDAC3 induced LC3B expression. Most importantly, we showed that HDAC3 is 
necessary to prevent lipid accumulation in response to amino acid deprivation in HepG2 cells. 
In conclusion, as summarized in Figure 4.9, our results demonstrated the potential 
mechanism by which a gestational and lactational LP diet increased hepatic lipid accumulation 
through autophagic degradation of ApoB and MTP. Understanding the role that HDAC3 played 
in the activation of LC3B and lipid accumulation will bring valuable insight into the epigenetic 
control of hepatic lipid accumulation, and the potential development of fatty liver disease caused 
by protein restriction.  
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4.6 Tables and Figures 
Table 4.1: Composition of diets 
	  Control (C) Low Protein (LP) 
Ingredients (g/kg) 20 kcal% protein 8 kcal% protein 
Casein 200 80 
L-Cystine 3 1.2 
Corn starch 397 519 
Maltodextrin 10 132 132 
Sucrose 100 100 
Cellulose, BW200 50 50 
Soybean oil 70 70 
Mineral Mix S10026 35 35 
Vitamin mix V10001 10 10 
Choline Bitartrate 2.5 2.5 
TBHQ 0.014 0.014 
Total 1000 1000 
Modified AIN-93 G diet    
Vitamin mix V10001 and Mineral mix S10026 are from Dyets, Inc, Bethlehem, PA. 
Table 4.2: List of primers 
Gene (Enzemble No.Transcript 
ID) 
  
Sequence 
  
Acc1  
(ENSRNOE00000323929) Rat mRNA 
Forward 
+2884F ATGAACACCCAGAGCATTGTCCAG 
    Reverse +2969R   AGCAGATCCATCACCACAGCCTT 
Fasn  
(ENSRNOT00000073321) Rat mRNA 
Forward 
+1747F CTTTGTGAGCCTCACCGCCAT 
    Reverse +1811R ATGCCATCAGGTTTCAGCCCC 
Mttp  
(ENSRNOE00000101363) Rat mRNA 
Forward 
+1042F TAGAACCTGAGAACCTGTCCAACGC 
    Reverse +1113R AAGTGCGGAGGTGCTGAATGAAG 
ApoB100 
(ENSRNOT00000046811) Rat mRNA 
Forward 
+2667F GCATCATCATCCCAGACTTCGCTA 
    Reverse +2734R GCCTGACTCGTGGAAGAAGTTTGTA 
Srebp1 
(ENSRNOT00000047053 ) Rat mRNA 
Forward 
+522F GCT TCT CTG GGC TCC TCT CTG G 
    Reverse +616R CAG TGG GTG CCG ATG GTG G 
Lipin2 
(ENSRNOT00000020476) Rat mRNA 
Forward 
+792F CCAGTTACCCACAGACAGTGTGCC 
  Rat Reverse +855R CTCTCGGATGGCTTCACCTCCA 
PPARg 
(ENSRNOE00000476355)   mRNA 
Forward 
+202F ATG GTT GAC ACA GAG ATG CC 
  Rat Reverse +290R AAG GAA TGG GAG TGG TCA TC 
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Table 4.2: List of primers (Continued) 
Cpt1a 
(ENSRNOT00000019652)   mRNA 
Forward 
+1027F GAGCGACTCTTCAATACTTCCC 
  Rat Reverse +1102R TGTGCCTGCTGTCCTTGATA 
Acox1 
(ENSRNOT00000042372)   mRNA 
Forward 
+433F GCCTTTGTTGTCCCTATCCGT 
  Rat Reverse +504R ACCGATATCCCCGACAGTGAT 
Hdac3 
(ENSRNOT00000060417)   mRNA 
Forward 
+61F GGACACCCGATGAAACCCCA 
  Rat Reverse +154R GGTAAGTCCAGCCCACGATCA 
Map1lc3a 
(ENSRNOT00000035060)   mRNA 
Forward 
+688F AGA AGG AAC ATT GCA GAG CTA AGC 
  Rat Reverse +767R TGG GGT GGA AAA GGA GGA TTC 
Map1lc3b 
(ENSRNOT00000051352) 
  Genomic 
DNA 
Forward -
244F AGC CAG GAG CAG AAG ATG AA 
Rat Reverse -156R TGA GTC GGC TTC CCA AAA 
  mRNA Forward +626F GTG TTG TGG AAG AAT GCC 
    Reverse +726R TCA CCC TTG TAT CGC TCT 
Map1lc3b 
(ENSE00001317431) Human mRNA 
Forward 
+633F CGT CGG AGA AGA CCT TCA A 
      Reverse +717R TTG GTT GGA TGC TGC TCT C 
Bnip3 
(ENSRNOT00000023477) Rat mRNA 
Forward  
+652F AAG GCG TCT GAC AAC TTC CA 
    Reverse +739R TCA CAG CTC AGC GTG AAT 
Atg4b 
(ENSRNOT00000025529) Rat mRNA 
Forward 
+24F GAG TGT TCT CAC TTT CCG 
    Reverse +113R ATC ACC ACA GTG TTG TCC 
Atg2b 
(ENSRNOE00000324498) Rat mRNA 
Forward 
+190F GCT ACA GCA CTA CTT GGG TC 
    Reverse +306R ACA GAC CAG GTT TCC AGG 
GAPDH (ENST00000229239) Human 
mRNA 
Forward 
+476F  TGC ACC ACC AAC TGC TTA GC  
    
Reverse 
+562R  GGC ATG GAC TGT GGT CAT GAG  	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Table 4.3: List of antibodies 
 
Cat. Number Lot No. Company name 
Name Modification 
Actin (I-19)-R  sc-1616-R C0907 Santa Cruz Biotechnology, Inc, Santa Cruz, CA 
H3Ac Ac-K9,14 06-599 DAM1422332 Upstates 
H4Ac Ac-K5,8,12,16 06-866 DAM1416550 Upstates 
H3K9Me3 M-K9 17-625 DAM1591824 Upstates 
H3S10p p-S10 sc-8656-R K1506 Upstates 
H3K4Me2 M-K4 07-030 DAM1570816 Upstates 
Normal rabbit IgG  sc-2027 F1608 Santa Cruz Biotechnology, Inc, Santa Cruz, CA  
ApoB (S-18)  sc-11795  Santa Cruz Biotechnology, Inc, Santa Cruz, CA 
MTP (N-17)  sc-33116  Santa Cruz Biotechnology, Inc, Santa Cruz, CA 
HDAC3  Ab16047  Abcam, Cambridge, MA 
LC3B  Ab48394 Lot 4 Abcam, Cambridge, MA 
 
Table 4.4: Biochemical analysis in rat dam 
 
Diet 
 Variable Control LP P value 
Blood glucose (mg/dl) 163.14± 15.30 152.29± 20.35 NS 
Liver TG (mg/dl) 24.76± 8.33 61.56±10.29 0.03 
Liver glycogen (ug/ul) 0.11± 0.01 0.07± 0.01 0.02 
Liver TG/glycogen 2.48± 0.94 10.02± 1.99 0.02 
Serum insulin (ug/l) 1.13± 0.23 0.46± 0.06 0.02 
Serum HDL (ug/ul) 0.83± 0.11 0.77± 0.10 NS 
Serum VLDL/LDL (ug/ul) 0.22± 0.02 0.13± 0.02 0.006 
Serum AST (U/l) 60.11± 5.02 60.42± 4.17 NS 
Serum ALT (U/l) 48.26± 7.32 26.86± 2.81 0.02 
Serum AST/ALT 1.40± 0.20 2.34± 0.41 0.006 
1. Values presented as Mean ± SEM, n=7. *Different from Control within each experiment, p<0.05 
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Figure 4.1: A LP diet throughout gestation and lactation altered maternal physiology and 
increased hepatic lipid accumulation in rats. Rat dams were fed either control (Control) or low 
protein (LP) diet throughout gestation and lactation. Values are means ± SEM, n=7. Asterisk (*) 
is used to identify the significance level compared to control (p<0.05). Food intake and body 
weight (A) and ratio of liver weight to body weight at weaning (B) during lactation. Two 
representative images were chosen to show the structural differences (H&E) and lipid 
accumulation (Oil Red O) in liver (C) between Control and LP groups. The ruler shows that 
standard range is 100 µm. Quantification of Oil Red O experiment (D) was analyzed by ImageJ 
software. X-axis represents the treatment group, while y-axis stands for the percentage of red 
stained area. Hepatic TG content (E) and serum VLDL/LDL level (F) are shown below. X-axis 
represents treatment, while y-axis stands for hepatic TG content (mg/dL). X-axis represents 
treatment, while the y-axis stands for serum VLDL/LDL content (ug/uL). 
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Figure 4.1	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Figure 4.2: mRNA expression of autophagy-related genes in rat dam after lactation. Values are 
means ± SEM, n=7. Asterisk (*) is used to identify the significance level compared to control 
(p<0.05). 	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 Figure 4.2	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Figure 4.3: LP diet inducted LC3B expression and acetylation in rats. Values are means ± SEM, 
n=7. Asterisk (*) is used to identify the significance level compared to control (p<0.05). Relative 
mRNA and protein expressions of LC3B (A) in rat liver. Data was normalized to Tbp. Whole cell 
protein extracts were collected from liver and subjected to immunoblotting with antibodies 
specific for LC3B. Actin was used to normalize the protein expression, ratio of LC3B-II to LC3B-
I. Confocal microscopy photographs of LC3B and BODIPY-stained fatty acids (B) in rats. Liver 
microscopy was followed the immunofluorescence protocol in “Materials and Methods”. DAPI 
stained nucleus, shown as blue. And LC3B antibody stained LC3B protein, shown as red. 
BODIPY-stained fatty acids showed as green. Abundance of LC3B (b, f, g, n, red), BODIPY (c, 
g, k, o, green) were shown. Quantification of LC3B and BODIPY immunofluorescence is in 
4.3C. X-axis represents treatments, while the y-axis stands for LC3B and BODIPY intensity, 
which was analyzed by ImageJ software.  Data was used as percentage of nucleus. Histone 
modifications (D) on the promoter of LC3b in rats. ChIP was applied to determine whether 
histone modifications including acetylation of H3 (H3Ac), acetylation of H4 (H4Ac), di-
methylation of H3 lysine 4 (H3K4Me2), tri-methylation of H3 lysine 9 (H3K9Me3), and 
phosphorylation of H3 serine 10 (H3S10p) were induced by LP diet in rats. IgG was used as a 
negative control. X-axis shows different histone modifications and y-axis shows protein DNA 
association (ratio to input). mRNA expression of Hdac3 in rats (E). mRNA expression was 
analyzed by two-step real-time RT-PCR. Data was normalized to Tbp. HDAC3 binding on the 
promoter of LC3b in H4IIEC3 cells (F). ChIP assay was applied to investigate the binding of 
HDAC3 on LC3b promoter in H4IIEC3 cells, a rat hepatoma cell line. 
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Figure 4.3
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Figure 4.4: Knockdown of HDAC3 increased LC3B expression and lipid accumulation in –AA 
treatment in HepG2 cells. Values are means ± SEM, n=3. Asterisk (*) is used to identify the 
significance level compared to control (p<0.05). HDAC3 mRNA and protein expression after 
HDAC3 knockdown in HepG2 cells (A). HepG2 cells were transfected with either NSsi (negative 
control) or HDAC3 siRNA for 48 h before incubating with −AA for 4 h. Whole cell protein 
extracts were collected and subjected to immunoblotting with antibodies specific for HDAC3 and 
LC3B. Actin was used to normalize the protein expression of HDAC3 and LC3B. X-axis 
represents treatments, while the y-axis stands for HDAC3 protein expression and normalized to 
Actin. Hdac3 mRNA expression (B). X-axis represents treatments, while the y-axis stands for 
Hdac3 mRNA expression and normalized to Gapdh. Quantification of LC3B protein expression 
after HDAC3 knockdown in HepG2 cells (C). X-axis represents treatments, while the y-axis 
stands for ratio of LC3B-II to LC3B-I, and normalized to Actin. LC3b mRNA expression (D). 
mRNA expression of LC3b in HepG2 cells after knockdown of HDAC3. mRNA expression was 
analyzed by two-step real-time RT-PCR in liver. Data was normalized to Gapdh. Oil Red O 
staining in HepG2 cells after HDAC3 knockdown in MEM or –AA treatment (E). Oil Red O was 
used to evaluate lipid abundance in HepG2 cells. Nucleus were stained as blue and lipids were 
shown as red. One representative image was chosen to show lipid accumulation between 
vector and HDAC3 plasmid. The ruler showed the standard range is 100 µm. Quantification of 
Oil Red O experiment (F). Results were analyzed by ImageJ software. X-axis represents the 
treatment group, while the y-axis stands for the percentage of red stained area. 
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Figure 4.4
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Figure 4.5: Overexpression of HDAC3 didn’t affect LC3B expression and lipid accumulation in 
HepG2 cells. Values are means ± SEM, n=3. Asterisk (*) is used to identify the significance level 
compared to control (p<0.05). HDAC3 and LC3B protein expression after HDAC3 
overexpression in HepG2 cells (A). HepG2 cells were transfected with either pcmv-empty 
(Vector) or pmcv-HDAC3 (HDAC3) plasmid for 48 h before incubating with −AA for 4 h. Whole 
cell protein extracts were collected from HepG2 cells and subjected to immunoblotting with 
antibodies specific for HDAC3 and LC3B. Actin was used to normalize the protein expression of 
HDAC3 and LC3B. Hdac3 mRNA expression (B). X-axis represents treatments, while the y-axis 
stands for Hdac3 mRNA expression and normalized to Gapdh. Quantification of LC3B protein 
expression after HDAC3 overexpression in HepG2 cells (C). X-axis represents treatments, while 
the y-axis stands for ratio of LC3B-II to LC3B-I and normalized to Actin. mRNA expression of 
LC3b after overexpression of HDAC3 in HepG2 cells (D). mRNA expression was analyzed by 
two-step real-time RT-PCR in liver.  Data was normalized to Gapdh. Oil Red O staining after 
HDAC3 overexpression in MEM or –AA treatment in HepG2 cells (E). Oil Red O was used to 
evaluate lipid abundance in HepG2 cells. Nucleus were stained as blue and lipids were shown 
as red. One representative image was chosen to show lipid accumulation between vector and 
HDAC3 plasmid. The ruler showed the standard range is 100 µm. Quantification of Oil Red O 
experiment (F). Results were analyzed by ImageJ software. X-axis represents the treatment 
group, while the y-axis stands for the percentage of red stained area. 
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Figure 4.5
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Figure 4.6: mRNA expression of lipid metabolism-related genes in rat dam after lactation (A). 
Values are means ± SEM, n=7. Asterisk (*) is used to identify the significance level compared to 
control (p<0.05). ApoC-I protein peptide sequence (B). 
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Figure 4.6
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Figure 4.7: LP diet induced co-localization of LC3B with ApoB and MTP in rats. LC3 binding 
motif was shown in ApoB and MTP peptide sequence (A). Protein sequences were found from 
NCBI database. ApoB and MTP LIR were shown according to the published LC3 binding motif 
sequence: W/Y/F-X1-X2-L/I/V. The red frame highlighted the predicted binding regions. 
Confocal microscopy photographs of LC3B and ApoB in rats (B). Liver microscopy was followed 
the immunofluorescence protocol in “Materials and Methods”. DAPI stained nucleus, shown as 
blue. And LC3B antibody stained LC3B protein, shown as red. ApoB showed as green. 
Abundance of LC3B (b, f, g, n, red) and ApoB (c, g, k, o, green) were shown. Merged images 
were generated from combination of DAPI, LC3B and ApoB. Quantification of LC3B and ApoB 
immunofluorescence (C). X-axis represents treatments, while the y-axis stands for LC3B and 
ApoB intensity, which was analyzed by ImageJ software, data was used as percentage of 
nucleus. Confocal microscopy photographs of LC3B and MTP in rats (D). Liver microscopy was 
followed the immunofluorescence protocol in “Materials and Methods”.  DAPI stained nucleus, 
shown as blue. And LC3B antibody stained LC3B protein, shown as red. MTP showed as green.  
Abundance of LC3B (b, f, g, n, red) and MTP (c, g, k, o, green) were shown. Merged images 
were generated from combination of DAPI, LC3B and MTP. Quantification of LC3B and MTP 
immunofluorescence (E). X-axis represents treatments, while the y-axis stands for LC3B and 
MTP intensity, which was analyzed by ImageJ software, data was used as percentage of 
nucleus. 
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Figure 4.7
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Figure 4.8: Protein expression of LC3B and lipid accumulation were affected by overexpression 
of LC3 and knockdown of LC3B in HepG2 cells. Values are means ± SEM, n=3. Asterisk (*) is 
used to identify the significance level compared to control (p<0.05). LC3B protein and mRNA 
expression after LC3B knockdown in HepG2 cells (A). HepG2 cells were transfected with either 
NSsi (negative control) or LC3B siRNA for 48 h before incubating with -AA for 4 h. Whole cell 
protein extracts were collected from HepG2 cells and subjected to immunoblotting with 
antibodies specific for LC3B. Actin was used to normalize the protein expression of LC3B-
II/LC3B-I.  mRNA expression was analyzed by two-step real-time RT-PCR in liver. Data was 
normalized to Gapdh. Oil Red O staining in HepG2 cells after LC3 knockdown in MEM or –AA 
treatment (B). Oil Red O was used to evaluate lipid abundance in HepG2 cells. Nucleus were 
stained as blue and lipids were shown as red. One representative image was chosen to show 
lipid accumulation between vector and LC3 plasmid. The ruler showed the standard range is 
100 µm. Quantification of Oil Red O experiment (C). Results were analyzed by ImageJ software. 
X-axis represents the treatment group, while the y-axis stands for the percentage of red stained 
area. LC3B protein and mRNA expression after LC3 overexpression in HepG2 cells (D). HepG2 
cells were transfected with either plpcx-GFP (Vector) or GFP-LC3 (LC3) plasmid for 48 h before 
incubating with -AA for 4 h. Whole cell protein extracts were collected and subjected to 
immunoblotting with antibodies specific for LC3B. Quantification of LC3B protein expression 
after LC3 overexpression in HepG2 cells was analyzed. X-axis represents treatments, while the 
y-axis stands for ratio of LC3B-II to LC3B-I and normalized to Actin. mRNA expression was 
analyzed by two-step real-time RT-PCR in liver.  Data was normalized to Gapdh. Oil Red O 
staining in HepG2 cells after LC3 overexpression in MEM or –AA treatment (E). Oil Red O was 
used to evaluate lipid abundance in HepG2 cells. Nucleus were stained as blue and lipids were 
shown as red. One representative image was chosen to show lipid accumulation between 
vector and LC3 plasmid. The ruler showed the standard range is 100 µm. Quantification of Oil 
Red O experiment (F). Results were analyzed by ImageJ software. X-axis represents the 
treatment group, while the y-axis stands for the percentage of red stained area. 
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Figure 4.8
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Figure 4.9: Schematic model that a LP diet throughout gestation and lactation decreased 
HDAC3 expression, which contributes to LC3B-induced hepatic lipid accumulation were shown.  
Our results highlight that repression of HDAC3 increased LC3b transcription and leaded to 
increased LC3B translation. Then, induced LC3B recruited lipid to facilitate autophagic 
degradation of ApoB and MTP. Pink dots showed as LC3B protein. Red dots showed as 
ApoB100, orange dots showed as MTP. The degradation of ApoB and MTP decreased VLDL 
synthesis, blocked lipid export and ultimately increased TG in liver. 
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Figure 4.9
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CHAPTER 5  
FUTURE DIRECTIONS 
 
A protein-restricted diet during gestation and lactation causes a series of adverse 
responses, including increased fat accumulation and impaired insulin secretion in the mother. 
Understanding how dietary protein deficiency affects the physiological and pathological 
consequences at the molecular level provides novel insight into the transduction of nutrient 
signals in the mother and the subsequent development of post-pregnancy and lactation 
maternal diseases. However, more research is needed to clearly establish how maternal 
physiology or the nutrients themselves are responsible for altered physiology observed in 
mother and offspring. 
 
Comparison Between Pregnancy and Non-pregnancy 
In the current study, a pregnancy and lactation rat model was used to investigate the 
physiological and molecular consequences of protein restriction. We showed that autophagy 
occurs in the skeletal muscle of both rat dams consumed a pregnancy protein-restricted diet 
and male offspring consuming control diet after weaning. Our study provides evidence of 
maternal programming. Additionally, a gestational and lactational protein restriction diet causes 
hepatic lipid accumulation and damage liver function in rat dam. Whether these observations 
also apply to non-pregnant animals is still unclear. Because protein restriction-induced muscle 
atrophy and hepatic lipid accumulation may be unique to pregnant or lactating animals, so 
similar studies in non-pregnant females, or even adult males, would provide valuable 
information about the universal impacts of protein restriction. 
 
Chronic Effects of Maternal Protein Restriction in Mother 
Numerous studies have shown that perinatal protein restriction shapes long-term health in 
offspring, which results in metabolic disorders such as obesity, diabetes, cardiovascular 
diseases, hypertension and others. However, the health of pregnant and lactating women is 
also a big concern, and in the current study, we showed that protein restriction could also 
influence a mother’s health. However, we lack evidence to show how long these adverse effects 
will last. A study is needed to investigate the long-term impacts of maternal protein restriction in 
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the mother. This result may reveal the hidden risks of protein restriction during pregnancy and 
lactation in the mother and bring attention to the long-term health of women in general. 
 
Primary Hepatocyte Culture from Pregnant and Non-pregnant Rats 
Primary cultures of rat hepatocytes are difficult to obtain and maintain, so we choose HepG2 
and H4IIEC3, human and rat hepatoma cell lines for the current analysis because they share 
many similarities to human primary hepatocytes and they are a well-established model for the 
investigation of molecular mechanism related to health outcomes in humans. Our cell culture 
analysis shows a direct relationship between amino acid limitation, lipid accumulation, induced 
autophagy and decreased Hdac3 mRNA expression. However, these two cell lines are cancer 
cell lines, and are therefore not precisely the same as cells derived from rat tissues. A primary 
culture of pregnant and non-pregnant rat hepatocytes would be an additional approach to 
further study the consequences of protein restriction during pregnancy and lactation on 
autophagy related pathways. 
 
Identify Specific Epigenetic Marks Inherited from Mother to Offspring 
Although it is important to determine specific epigenetic modifications governing the regulation 
of maternal and fetal development, it is more imperative to clarify how these changes contribute 
to the overall health of mother and offspring. The activation of the mammalian autophagy-
related pathways may act as a cue for the mother to develop an adaptive response suited to the 
predicted prenatal and postnatal environment but could in turn increase their vulnerability to 
developing short-term and long-term diseases. A clear understanding of which specific 
epigenetic marks are the primary contributors to the programming of diseases in offspring will 
help us develop targeted therapies to manage the adverse influences of early exposures. 
Moreover, more studies are needed to address whether these adverse impacts in mother and 
offspring can be ameliorated or reversed. Because autophagy is a critical regulator of cell 
survival and cell death, it is essential to understand how epigenetics play a role in the regulation 
of autophagy, which will shed light on identifying unique epigenetic markers for disease 
prevention and intervention during early development and in later life. 
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APPENDIX : EXPERIMENTAL PROTOCOLS USED IN THIS STUDY 
 
Oil Red O staining 
Cells 
1. After cell culture treatment, suck up medium and rinse wells with 2 mL PBS (swirl). 
2. Add 1 mL pre-warm 4% paraformaldehyde into each well. 
3. Incubate at room temperature for 30 min for fixation. 
4. After fixation, suck up and rinse wells with 1 mL 1x PBS. 
5. Wash wells with filtered H2O, 2 mL per well for 1 min. 
6. Use fresh-made 60% isopropanol; soak the wells for 1 min (1 mL each). 
7. Dilute Oil red O reagents (WAKO) with filtered H2O to 60% solution. 
8. 1 mL ORO solution added to each well, and incubates for 10 min. 
9. Wash with 60% isopropanol for 1 mL. 
10. After incubation, suck out the solution, wash with 2 mL filtered H2O. 
11. Use tweezer to get cover slides from 6-well plate, wash with filtered H2O for 5 s. 
12. Dip into the hematoxylin for 20 s. 
13. Wash with filtered H2O until no more purple color coming out. 
14. Use Aqua-mount, 1 drop on the slide, put the cover slide on the slide (No bubble). 
15. Use kimwipe to stabilize the cover slide. 
16. Dry overnight at room temperature.  
17. Use Nanozoomer from IGB for imaging.  
Tissue 
1. Liver tissue is cut using cryostat in IGB core facility (5~7 um), samples are store at -20 °C. 
2. Frozen liver slides are taken out and dry in the hood for about 1 h. 
3. Rehydration: Samples go through 100% Alcohol, 75% Alcohol, PBS and H2O, each step 5 min. 
4. From this step, the rest of steps follow the step 6 in Cell section. 
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H&E staining 
 
Reagents preparation: 
100 and 70% Ethanol 
Eosin Y 
Clarifier (Commercial bottle, this is not diluted) 
Xylene  
Hemotoxylin (Commercial bottle, this is not diluted) 
Aquamount and Nail Polish (Clear Coat/Finish) 
 
General Steps	  
1. Place slides in the metal slide holder 
2. Dunk the slide holder in a container of 70% ethanol for 1 minute to fix and remove OCT 
3. Dunk the slide holder in a container of dH2O for about 30 s or until clear. 
4. Place the slide holder in hemotoxylin for 30 s. 
5. Place the slide holder in a container of Clarifier for 30 s. This solution needs to be discarded after 
one time of use.  
6. Place the slide holder in an empty container, in the sink, and let distilled water run into the 
container for 30 seconds. Make sure the stream is not falling directly on your slides 
7. Place the slide holder in a container of Eosin Y for 30 s.  
8. Place the slide holder in a container of 100% ethanol for 30 s.  
9. Place the slide holder in a different container of 100% ethanol than step 8 for 30 s.  
10. Place the slide holder in a different container of 100% ethanol than steps 8 and 9 for 30 s.  
11. Place the slide holder in a container of Xylene for 30 s.  
12. Place the slide holder in a different container of Xylene than step 11 for 30 s.  
13. Add 2-3 drops of Aquamount to the slides. 
14. Mount coverslip. 
15. Turn the slide over and press down gently, DO NOT SLIDE the coverslip and the glass slide, this 
will distort your sample. 
16. Let sit for overnight. 
17. Use the nail polish to seal the edges. 
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Glycogen Measurement  
 
Glycogen Standards for Colorimetric Detection: (Sigma-Aldrich, glycogen assay kit, MAK016) 
Dilute 10 μL of the 2.0 mg/mL Glycogen Standard with 90 μL of distilled water to prepare a 0.2 mg/mL 
standard solution. Add 0, 2, 4, 6, 8, and 10 μL of the 0.2 mg/mL standard solution into a 96 well plate, 
generating 0 (assay blank), 0.4, 0.8, 1.2, 1.6, and 2.0 μg/well standards. Add Hydrolysis Assay Buffer to 
each well to bring the volume to 50 μL. 
 
Sample Preparation 
1. Frozen liver tissue (~10 mg) was homogenized in 100 μL of water on ice. 
2. Boil homogenates for 5 min to inactive enzymes. 
3. Centrifuge samples at 13,000 x g for 5 min to remove insoluble material. 
4. Bring samples to a final volume of 50 μL with Hydrolysis Buffer from the kit. 
 
Assay Reaction 
1. Add 2 μL of the Hydrolysis Enzyme Mix to colorimetric assays, mix well, and incubate for 30 
minutes at room temperature. Check: Glucose in the samples will generate a background signal. 
To remove the effect of glucose background, a sample blank may be set up for each reaction by 
omitting the Hydrolysis Enzyme Mix. The sample blank can then be subtracted from the sample 
readings. 
2. Set up the Master Reaction Mix according to APPENDIX A Table 1. 50 μL of the Master 
Reaction Mix is required for each reaction (well).  
3. Add 50 μL of the Master Reaction Mix to each of the wells. Mix well using a horizontal shaker or 
by pipetting, and incubate the reaction for 30 minutes at room temperature. Protect the plate from 
light during the incubation.  
4. Measure the absorbance at λ 570 nm. 
APPENDIX Table A.1: Master reaction Mix 
Reagent  Volume  
Development Buffer  46 µL  
Development Enzyme Mix  2 µL  
Fluorescent Peroxidase Substrate  2 µL  
 
Calculations 
The background for the assays is the value obtained for the 0 (assay blank) glycogen standard. Correct 
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for the background by subtracting the assay bank value from all readings. Background values can be 
significant and must be subtracted from all readings. Use the values obtained from the appropriate 
glycogen standards to plot a standard curve. 
Note: A new standard curve must be set up each time the assay is run.  
Subtract the sample blank value from the sample readings to obtain the corrected measurement. Using 
the corrected measurement, the amount of glycogen present in the sample may be determined from the 
standard curve.  
 
Concentration of Glycogen 
Sa/Sv= C 
Sa = Amount of glycogen in unknown sample (μg) from standard curve 
Sv = Sample volume (μL) added into the wells 
C= Concentration of glycogen in sample 
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VLDL/LDL Measurement 
 
Cholesterol Standards for Colorimetric Detection: (Sigma-Aldrich, HDL and LDL/VLDL Quantification kit, 
MAK045) 
Dilute 20 μL of the 2 μg/μL Cholesterol Standard Solution with 140 μL of the Cholesterol Assay Buffer 
to prepare a 0.25 μg/μL standard solution. Add 0, 4, 8, 12, 16, and 20 μL of the 0.25 μg/μL 
Cholesterol Standard solution into a 96 well plate, generating 0 (blank), 1, 2, 3, 4, and 5 μg/well 
standards. Add Cholesterol Assay Buffer to each well to bring the volume to 50 μL.  
Sample Preparation 
Separation of HDL and LDL/VLDL: Mix 100 μL of the 2× Precipitation Buffer with 100 μL of the serum 
sample in a microcentrifuge tube. Incubate for 10 minutes at room temperature and then centrifuge the 
samples at 2,000 × g for 10 minutes. The precipitant contains the LDL/VLDL fraction. To measure 
LDL/VLDL, centrifuge the samples again at 2,000 × g for 10 minutes and remove any remaining trace 
HDL supernatant. Resuspend the precipitate in 200 μL of PBS. Bring samples to a final volume of 50 μL 
with Cholesterol Assay Buffer. 
 
Assay Reaction 
1. Set up the Reaction Mixes according to the scheme in APPENDIX A Table 2. 50 μL of the 
appropriate Reaction Mix is required for each reaction (well).  
2. Add 50 μL of the appropriate Reaction Mix to each of the wells. Mix well using a horizontal 
shaker or by pipetting, and incubate the reaction for 60 minutes at 37 °C. Protect the plate from 
light during the incubation.  
3. Measure the absorbance at λ 570 nm. 
 
APPENDIX Table A.2: Master reaction Mix 
Reagent  Total Cholesterol and Standards  Free Cholesterol  
Cholesterol Assay Buffer  44 μL  46 μL  
Cholesterol Probe  2 μL  2 μL  
Cholesterol Enzyme Mix  2 μL  2 μL  
Cholesterol Esterase  2 μL  –  
 
Calculations 
The background for this assay is the value obtained for the 0 (blank) cholesterol standard. Correct for the 
background by subtracting the blank value from all readings. Background values can be significant and 
must be subtracted from all readings. Use the values obtained from the appropriate cholesterol standards 
to plot a standard curve. The amount of cholesterol present in the samples may be determined from the 
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standard curve. 
Note: A new standard curve must be set up each time the assay is run.  
 
Concentration of Cholesterol 
(Sa/Sv) x Df* = C 
Sa = Amount of cholesterol in unknown sample (μg) from standard curve 
Sv= Sample volumne (μL) added into the wells 
C= Concentration of cholesterol in sample 
Df = The dilution factor will be 2 due to the 1: 1 dilution with the 2x Precipitation buffer. If the sample 
requires further dilution with PBS, the factor will need to be adjusted accordingly. 
Cholesterol molecular weight: 386.65 g/mole.  
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Triacylglyceride (TAG) Measurement 
 
Dilution of standards: (Verichem Laboratories, Providence, RI) 
1. 245 mg/dL –B Matrix Plus (no dilution) 
2. 200 mg/dL – 81.6 ul B Matrix Plus + 18.4 ul 1X PBS (Use for next 3 dilutions) 
3. 150 mg/dL – 37.5 ul of #2 dilution + 12.5 ul 1X PBS 
4. 100 mg/dL – 20 ul of #2 dilution + 20 ul 1X PBS 
5. 50 mg/dL – 8.8 ul of #2 dilution + 26.3 ul 1X PBS 
a. 10 mg/dL – A Matrix Plus (no dilution) 
Reference blank – 1X PBS 
 
Protocol: 
1. Frozen liver samples (~50 mg) were ground in liquid nitrogen and homogenized in 0.3 mL saline 
(0.9% w/v NaCl). 
2. Homogenized samples were diluted 5 times with saline.   
3. Ten µL of the diluted samples were incubated with 20 μL 1% deoxycholate in 37 ºC for 5 min. 
4. Vortex each sample, 5 µL of the sample was analyzed using the Thermo Infinity Triglycerides 
Liquid Stable Reagent (Thermo Fisher Scientific, Rockford, IL) and a standard reference kit to 
determine the TAG content.  
5. Add 200 µL of TAG reagent into all wells. 
6. Assay at λ 562 nm. 
7. The results of hepatic TAG were normalized to the amount of total protein in the sample. 
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Chromatin Immunoprecipitation (ChIP) 
 
Day 1 
Cells 
1. By the end of the treatment, add 0.27 mL 37 % Formaldehyde to the plate (final concentration 1%).  
Use 10 mL minimum of media for each 150 mm plate.   
2. Shake for 10 min at room temperature.   
3. Add 0.64 mL 2 M Glycine to a final concentration of 0.125 M (16X dilution).   
4. Shake for additional 5 min at room temperature.  
5. Scrape off cells and collect in 50 mL screw-capped tubes. About 23 mL per condition. Can 
move on to next step or store. To store, flash freeze with liquid nitrogen. Store at -70 °C.   
Tissue	  
1. Grind tissue in liquid nitrogen (~200 mg each sample for 10 IP) into 15 mL tubes. 
2. Fixing Tissue: to ground sample, add 3 mL cold PBS+83 µL 37 % formaldehyde (1 % final). 
3. Rotate 10 min at room temperature. 
4. Add 205 µl 2 M glycine (final 0.125 M) to each sample. 
5. Rotate 5 min at room temperature. 
**TO STOP HERE: Flash freezes samples in liquid nitrogen and store in -70 °C.  
 
Day 2  
6. Thaw in 37 °C water bath if necessary. 
7. Centrifuge 10 min at 20 °C, 2,500-5,000 rpm.  Pour off supernatant. 
8. Add adequate amount of cold PBS. Vortex. Centrifuge 10 min at 20 °C, 2,500-5,000 rpm.  
Pour off supernatant. 
9. Repeat wash with 5 more mL cold PBS. Vortex. Centrifuge for 10 min at 20°C, 2,500-5,000 
rpm.  Pour off supernatant. 
10. Add 1 mL cold Nuclei Swelling Buffer (NSB) with proteinase inhibitor (P.I.) and phosphatase 
inhibitor cocktail 2&3 (PIC2 and PIC3).  Pipette to mix, do not vortex. 
a. Per sample: 1 mL NSB + 100 µL (10x) P.I. + 10 µL PIC2 + 10 µL PIC3 
11. Transfer all samples from 15 mL tubes to 2mL microcentrifuge tubes. 
a. Keep on ice for 10 min. 
b. Centrifuge for 5 min at 4°C, 5000 rpm 
c. Discard supernatant 
12. Add 1 mL SDS Lysis Buffer with P.I., PIC2 and PIC3.  Pipette to mix, do not vortex. 
a.  Per sample: 1 mL SDS Lysis Buffer + 100 µL (10x) P.I.+ 10 µL PIC2 + 10 µL PIC3 
13. Gently pipette to transfer each sample to a 4 mL glass conical tube pre-labeled with sample 
number (see 15c below and use 2 tubes if necessary, be sure to label both). 
14. Incubate on ice for 10 min. 
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15. Use the water bath sonication system 
a. Connect the tubes to the chamber, chillers and monitor according to the 
information on the machine and tube. Set the water bath, fill with DI water to cover 
the input and outlet in the chamber and make sure the temperature reaches the 
lowest temperature on the chiller. 
b. Turn on the water cycling system and the chiller. 
c. Since each sample has ~1 mL volume, separate into 2 conical sonication tubes 
(500 µL each). 
d. Install the sonication tube to the black holder, secure the sonication rotator with the 
white cover. 
e. Sonication setting: Timer: 00:30:00; Pulse on: 20 sec; Pulse off: 40 sec; AMPL: 
100% (Should be pre-set, just confirm) 
f. Turn on the sonication. While sample is sonicating, make sure the temperature is 
still cool (monitor the temperature every 10 min, if the temperature is too high, you 
will manually stop the sonication after 1 hr and cool down the water bath, and start 
another hr sonication). 
g. Clean and dry the chamber and connecting tubes completely. The probe should be 
kept dry when not in use. 
 
16. Transfer each sample to 1.5 mL microcentrifuge tubes (If using the water bath system, make 
sure to combine both samples from the glass sonication tubes) 
a. Centrifuge 10 min at 4°C, 13,000 rpm to pellet cell debris. 
17. Transfer each supernatant to 15 mL tubes 
18. Add 9mL ChIP Dilution Buffer to each 1 mL supernatant, invert to mix. 
a. This solution can be stored at 4°C for any future antibody incubations. 
 
Checkpoints: Make sure the chromatin is sheared to ~ 500 bp by running a DNA gel. Take 
50 µl from each tube and reverse crosslink by adding 2 µl of 5 M NaCl and incubating at 65 
°C for >2 hrs.  Do phenol-CHCl3 extraction once.  Add phenol-chloroform to the tube, vortex 
thoroughly. Then take out the clear phase and transfer to a new tube. Run 1-2 µl on a 1.6 % 
agarose gel to check the result of sonication.   
 
Day 3 
 
19. Wash Dynabeads® Protein G beads (Life tech) with PBS/T (0.02% Tween20). Shake the 
mixture several times and use magnetic rack to vacuum out the liquid. 
Per sample: 15 µL magnetic beads + 200 µL PBS/T. 
20. Capturing beads-antibody Complex: 
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a. Add 200 µL PBS/T and 1 µg antibody to each sample (check the concentration of the 
stock antibody. Typically: 2.5 µL for IgG that are 200 µg/0.5 mL, and 5 µL for other 
antibodies at 200 µg/mL) 
b. Place in small box and rotate for 1 hr at room temperature. 
21. Centrifuge 1 min at room temperature, 2,000 rpm to pellet beads. Vacuum out the liquid using 
a gel-loading tip. 
22. Wash the complex with 500 µL PBS/T, shake it several times, apply magnetic rack to pellet 
the beads and vacuum out the liquid.  
23. Add 750 µL of diluted ChIP samples to tubes containing washed and prepared Dynabeads. 
24. Rotate for 2 hrs at room temperature. 
25. From IgG samples:  pipette out and transfer 1000 µL (1mL) of the supernatant into another 
set of tubes, labeled with each sample’s name and “Input”.  Keep this set in 4 °C until clean-
up. This contains all chromatin and will be used for normalization. 
26. For all other samples (and anything left in IgG):  using magnetic rack to pellet the beads and 
aspirate all supernatant using gel-loading tips (0.2 mm). 
27. Perform washes in the following order, each time adding 1 mL solution to each sample, 
rotating on a rack for 5 min at room temperature, then centrifuging 1 min, 2,000 rpm. Vacuum 
out the liquid, and repeat. 
a. Low Salt Wash 
b. High Salt Wash 
c. Lithium Chloride (LiCl) Wash 
d. TE, pH 8.0 
e. TE, pH 8.0.  Remove all supernatant. 
28. Add 250 ul freshly prepared Elution Buffer to each sample 
a. Buffer should be prepared immediately before beginning washes and warmed in 
65°C bath. 
b. 1 % SDS + 0.1 M NaHCO3: (Per sample: 400 µL RNAase-free H20 + 50 µL 10%SDS 
+50 µL NaHCO3) 
i. For 10 tubes (6 mL) = 4.8 mL RNAase-free H2O + 0.6 mL 10% SDS + 0.6 mL 
1M NaHCO3 
ii. For 50 tubes (30 mL) = 24 mL RNAase-free H2O + 3 mL 10% SDS + 3 mL 
1M NaHCO3 
29. Vortex all samples, take to bacterial shaker to shake for 15 min at 42°C, 300 rpm. 
30. Centrifuge samples 1 min at room temperature, 2,000 rpm. 
31. Transfer and SAVE supernatant to new freshly labeled tubes. 
32. Add additional 250 µL freshly prepared Elution Buffer to each sample. 
33. Vortex all samples, take to bacterial shaker to shake for 15 min at 42 °C, 300 rpm. 
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34. Centrifuge samples 1 min at 4 °C, 2,000 rpm. 
35. Transfer and SAVE supernatant to tubes that contain the first 250 µL elution, for a total of 500 
µL of each sample. 
36. Save the beads by resuspending with 200-300 µL TE, sorted according to different antibodies 
(can be done later, as long as beads aren’t dry) and store at 4 °C. 
**Include the “Input” samples for all further steps 
37. Reverse crosslinking: add 20 µL 5M NaCl + 1 µg RNase A (10 µL, 100 µg/mL) per tube 
a. Prepare master mix for all samples while samples are in the shaker. 
38. Incubate 5 hrs at 65 °C. 
39. Store at 4 °C before purification. 
 
Day 4 
40. Proteinase K treatment: Add 10 µL 0.5 M EDTA + 20 µL 1 M Tris-HCl, pH 6.5 + 1 µL 
Proteinase K, 20 mg/mL. 
a. Make enough for all samples 
i. For 70 samples: 700 µL 0.5 EDTA + 1400 µL 1M Tris-HCl, pH 6.5 + 70 µL 
Proteinase K, 20 mg/mL. 
41. Incubate for 1hr in 37 °C water bath. 
42. DNA cleanup using QIAqen plasmid Purification Kit (protocol based on manufacturer’s 
instructions): 
a. Assemble the vacuum for column purification, hook it up to the vacuum outline and 
block the other outlet. 
b. IP samples (no Input):   
i. Add 2 mL PB buffer to each tube  
ii. Transfer 500 µL of IP samples to labeled round-bottom glass tubes (Fisher). 
Vortex gently (on low speed) to make sure it is homogenized. Do not spill! 
iii. Transfer 850 µL of mixture to each labeled column. 
iv. Open the vacuum.  
v. Load the remaining liquid (or until all volume has run through the column). 
c. “Input” samples:  (Prepare 2 sets of “input” samples: Input 1 as template for PCR and 
Input 2 for generating the PCR standard) 
i. Add 2 mL PB buffer to each tube  
ii. Add 100 µL of saved “input” samples to each column. Vortex gently (on low 
speed) to make sure it is homogenized. Do not spill! 
iii. Transfer 850 µL of mixture to each labeled column. 
iv. Open the vacuum.  
v. Load the remaining liquid (or until all volume has run through the column). 
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d. Wait until all liquid has run through column and turn off the vacuum input.  
i. Add 750 µL PE buffer to each column, including both “Input”s 
ii. Open the vacuum.  
iii. Wait until all the liquid has run through the column. 
iv. Place each column into the old 2 mL white tube and spin down at 13,000 rpm 
at room temperature to dry to column. 
v. Label a NEW set of 1.5 mL microcentrifuge tubes. 
vi. Add 100 µL EB buffer, let stand at room temperature for >1 min, centrifuge 
for 1 min at room temperature, 13,000 rpm to elute DNA to the NEW 
prelabeled microcentrifuge tube.  
43. Making PCR standard: 
a. Label 6 - 1.5 mL microcentrifuge tubes (1:4 dilution): 1.0, 0.25, 0.0625, 0.015625, 
0.00390625, 0.0009765625. 
b. To make a serial dilution, using “Input 2” samples, combine all samples into 1 tube 
(1.5 mL microcentrifuge).  This tube is “1.0”. 
c. Take out a quarter of the volume of “1.0”, add it to equal volume TE in tube “0.25”. 
Vortex and spin down. Continue the serial dilution until the final dilution. 
44. qRT-PCR reaction: 
a. Load 2 µL of each sample as well as each standard in a 10 µL reaction volume, as 
for all PCR reactions. Use Power SYBR Green. Use results from “Input” to normalize 
data for each IP sample. 
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Example of Gene Silencing of Adherent Cells Using Lipofectamine RNAiMax Transfection 
Reagent (Reverse Transfection Protocol) 
 
Date:  Plating and transfection: 2014/09/15, Transfection: Length: ~60 h ; Treatment:  refresh  
MEM/-AA, on PM 9/17 (48h transfection); treatment: 12 h 9/18, collect for RNA and protein. 
 
0.3 milx 18 wellsx 4= 21.6 mil in 115.2 (118) mL complete mem (without ABAM).  
 
 
9/15/14: rev transfection/plating; 
Set up each tube and incubate for 5 min at r/t; 
Aliquot amount from tube #2 to each tube #1 and mix; incubate extra 20 min; 
To each well aliquot 400 uL RNAi duplex-Lipofectamine RNAiMAX complexes.  
Dilute HepG2 cells in complete growth medium without antibiotics so that 1.6 ml contains 
0.3 x106  
Cells   
Add 1.6 ml of the diluted cells to each well. Mix gently by rocking the plate back and forth; 
Incubate for 48 hr; 
9/17/14: refresh media 12-16 hr before –AA treatment  
9/18/14: Start MEM −AA treatment for 12 hr and sample time 0. 
  
Cell 
type 
Date Thawed, 
passage No. 
Cell 
No./well  
Plate 
format 
Total dishes No. of siRNA Replicates/si 
HepG2 P2 9/5 0.3 x106  
 
6 well 
plate 
 
12 6-well 
plates  
3 per siRNA 
 
N/S si; hAtg5: si 
#1&2&3;hHDAC3  
si #1&2&3 
hLC3B: si 
#1&2&3 
18 wells: 3 RNA+ 3 
Protein )  
Trt: MEM/-AA 
0, 12 h 
test # and name 
Tube 1 
siRNA duplex 
Tube 2 
Lipofectamine 
Dilute cells in 
growth MEM 
(mL) 
30 nM final conc (20 uM 
stock, 1 uL each duplex) 
serum-
free 
MEM  
per well        
total 
 (uL) 
#2 
per well  per tube 1  total (uL) 
serum-free MEM 
per well  per tube 1  total (mL) 
Per well      total 
(uL) 
1 N/S si  3             54 µL 197                 3.6 mL 7 µL           126 µL            504 µL 
serum-free MEM 
193            3.5 mL           14 mL 
 
Add 3.6 ml to each tube #1 
 
Aliquot 400 µL per well  
 
1.6 mL  
per well for 6-
well 
 
2 Atg5 si dup#1,2,3  3             54 µL 
197                 
3.6 mL 
3 HDAC3 si  dup#1,2,3 3              54 µL  
197                 
3.6 mL 
4 LC3B si dup#1,2,3  3             54 µL 
197                 
3.6 mL 
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Example of Transfection of Adherent Cells Using Superfect Transfection Reagent 
(QIAgen) 
 
Transfection Study Planning Form 
 
Date: Cell plating: 10/26/2014 , Transfection:  10/27/2014     ,  Change media:    
10/27/2014(3hr);10/28/2014 ,   Treatment:  MEM, −AA (4h) Collect cells on 10/29/2014  
 
 
 
6-well: 1 ml media 
 
1. Mix samples for 5-10 min at R.T. 
2. Change to the growth media in the well 
3. Add DNA-Superfect complex to each well, after it is done, shake the plate 2-3 times to 
mix 
4. Incubate at 37 °C  for 3 hrs 
5. Replace to the growth media 
6. Change media at day1 (replenishment) 
7. Treat with Amino acid free medium for 4hrs and collect samples at day2 on 10/29/2014 
  
Cell 
type 
Date Thawed, 
passage No. 
Cell 
No./well  
Plate 
format 
Total 
dishes 
No. of 
tests 
No. of Treatments Replicates 
HepG2 10/14/14  P3 0.4 X106 6 well 6 36 1RNA+1protein+1 
ORO slides 
3 
test # 
Testing Plasmid (conc.) 
 Final Vol of DNA in medium (µL)  Superfect (µL) 
Aliquot/well 
(µL) µg/ well x # of wells         total µL needed 
1 pCMV-empty (0.7 µg/µL) 3 µg / .7*18    77 µL  
200 x 18  
total 3600 
10 x 18 
180 
210 µL/1ml for 
6-well 
2 pCMV-HDAC3 (0.51 µg/µL) 3 µg / .51*18   105.9 µL  
200 x 18  
total 3600 
10 x 18 
180 
215 µL/1ml for 
6-well 
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